SlideShare a Scribd company logo
1 of 13
Download to read offline
J
United States Patent [191 ·
Hemphill et al.
[54] PROCESS FOR REGENERATING
SOYBEANS
[75] Inventors: John K. Hemphill, Cupertino; Claire
A. Warshaw, Palo Alto, both of Calif.
[73] Assignee: Sungene Technologies Corporation,
Palo Alto, Calif.
[ • ] Notice: The portion of the term ofthis patent
subsequent to Aug. 4, 2004 has been
disclaimed.
[21] Appl. No.: 890,302
[22] Filed: Jul. 29' 1986
[51] Int.Cl.4 ............................................... C12N5/00
[52] U.S. Cl•............................ 435/240.49; 435/240.5;
435/240.54
[58] Field of Search ............ 435/240.5, 240.49, 240.54
[56] References Cited
U.S. PATENT DOCUMENTS
4,003,156 1/1977 Sibi et al. .
4,684,612 8/1987 Hemphill et al. ................ 435/240.5
OTHER PUBLICATIONS
Hu et al., 1983, p. 213, In: Handbook of Plant Cell Cul-
ture, vol. 1, Evans et al., eds., Macmillan: New York.
Stuart et al., 1984, Plant Sci. Lett. 34:165-174.
Tilton et al., 1984, J. Plant Physiol. 115:191-200.
[11] Patent Number:
[45] Date of Patent:
4,837,152
*Jun. 6, 1989
Phillips et al., Plant Cell Tissue Organ Culture 1, 123
(1981).
Widhalm et al., Plant Cell Reports 2, 19 (1983).
Gamborg et al., Plant Cell Repons 2, 209 (1983a).
Gamborg et al., Plant Cell Repons 2, 213 (1983b).
Christianson et al., Science 222, 632 (1983).
Ranch et al., In Vitro Cell Develop. Biol. 21, 653 (1985).
··Barwale et al., Planta 167, 473 (1986).
Kerns et al., Plant Cell Repons 5, 140 (1986).
Lazzeri et al., Plant Malec. Biol Rptr. 3, 160 (1985).
Li et al., Plant Cell Reports 4, 344 (1985).
Grant, Plant Cell, Tissue and Organ Culture 3, 169
(1984).
Wright et al., Plant Cell Repons 5, 150 (1986).
Cheng et al., Plant Science Letters 19, 91 (1980).
Saka et al., Plant Science Letters 19, 193 (1980).
Kameya et al., Plant Science Letters 21, 289 (1981).
Ghazi, T. D. et al., Plant Cell Reports 5, 452 (1986).
Primary Examiner-Charles F. Warren
Assistant Examiner-David T. Fox
Attorney, Agent, or Firm-Robbins & Laramie
[57] ABSTRACT
The present invention relates to the regeneration of
soybeans. The process comprises the steps of inducing
callus and embryoid formation from tissue of a soybean
plant, maturing the embryoids, germinating the ernbry-
oids, and forming roots on the germinated embryoids.
32 Claims, No Drawings
~ ,.
:-~
:--·:.
... •
..
::·...
.. ·•
.. .
4,837,152
1
PROCESS FOR REGENERATING SOYBEANS
2
containing 0.5 mg/I a-naphthalene acetic acid (NAA)
followed in series by MS basal medium containing 0.5
mg/l of indoleacetic acid (IAA) and 5 mg/l benzylade-
nine (BA), and finally MS basal medium containing 0.5CROSS REFERENCE TO RELATED
APPLICATION 5 mg/l BA.
The present invention is related to copending applica-
tion Ser. No. 635,222, filed July 27, 1984, U.S. Pat. No.
4,684,612, incorporated by reference herein.
Gamberg et al., in Plant Cell Reports 2, 209 (l983a),
disclose somatic embryogenesis from cell suspension
culture in several Glycine species including three culti-
vars (out of seven tested) of Glycine max. The embryoid
BACKGROUND OF THE INVENTION 10 induction medium utilized consisted of the major salts
1. Field of the Invention · ·
The present invention relates to an improved process
for regenerating soybeans (Glycine max (L.) Merrill).
More particularly, the invention relates to the use of
tissue and cell culture for the regeneration of soybean 15
plantlets for many soybean varieties. The invention also
relates to the media used in this process.
· of SL; the micronutrients -and vitamins of BS, 10 mg/I
casamino acids, 15 µM adenine sulfate, 0.2 µM picloram
and 0.025-0.25 µMAMO 1618. It was discovered that
picloram was necessary for embryo induction and that
it could be replaced by 0.5 to 2.0 µM 2,4-D. No embry-
oids were induced when the auxins NAA, lAA or in-
2. Description of the Prior Art
Plant regeneration from cells in culture is essential for
the application ofsomatic hybridization, for the produc- 20
tion of new varieties through somoclonal variation and
for the use of genetic engineering in producing new
varieties. Although plants can be regenerated from
single cells of a large number ofcrop species, the efforts
with soybean have generally been unsuccessful. 25
In recent years, plant cell culture successes have had
a considerable influence on the understanding of the
respective roles of cell and organism in control of plant
growth and development. Isolated plant cells have been
shown to be amenable to in vitro culture and complete 30
plants could be regenerated from cultures derived from
somatic cells, either directly via somatic embryogenesis
or indirectly via organogenesis. Generally the regenera-
tion pathway of choice is determined empirically by the
manipulation of extrinsic factors, especially growth 35
regulators. Early investigations of certain plant species
have suggested that exogenous auxin concentration is
the major factor controlling somatic embryogenesis,
such that its reduction leads to the initiation of embry-
oid formation. In other species, exposure to a definite 40
balance of auxin and cytokinin leads to the formation of
organogenesis (shoots, then roots).
Phillips et al., in Plant Cell Tissue Organ Culture. 1,
123 (1981), described the somatic embryogenesis of
soybean in cell suspension or on agar. They utilized 45
hypocotyl or epicotyl tissue for callus initiation on L2
medium. Cell suspension cultures were initiated from
callus tissue in S2 medium. The cell suspension culture
could be used to produce globular and heart-shaped
embryos or additional callus which could form shoot 50
buds. The formation of somatic embryos or shoot buds
was reproducible using basal S2 or L2 media supple-
mented with 100 mg/l casein hydrolysate, 2.25 µM
2,4-dichlorophenoxyacetic acid (2,4-D), 0.1 µM abscisic
acid (ABA), 0.1 µM 2-isopropyl-4-dimethylaminoS- 55
methylphenyl-1-piperidine carboxymethyl chioride
(AMO 1618) and either 15 µM adenine or 0.46 µM
kinetin. Although somatic embryos or shoot buds were
formed, on plants were obtained for any varieties of
Glycine max. 60
Wildholm et al., in Plant Cell Reports 2, 19 (1983),
describe the formation of shoots from Glycine canescens
callus obtained from hypocotyls or cotyledons. Root
formation did not occur, so no plantlets were obtained.
The method did not produce shoots when Glycine max 65
(soybean) was the source of the tissue. The formation of
shoots from Glycine canescens tissue culture was
achieved through callus induction on BS basal medium
dole-3-butyric acid (IBA) were utilized in place of the
auxins picloram or 2,4-D. After embryoids were in-
duced, they were transferred to embryo growth me-
dium which consisted of SL medium containing various
combinations of cytokinins (zeatin or BA), auxins (pi-
cloram) and gibberellic acid (GA3). Embryoids which
were formed went to a heart-shaped structure, but
failed to develop beyond this stage on the induction
medium. Transfer to the growth medium did result in
the formation of roots, but shoots were not formed. The
use of MS medium or addition of abscisic acid, coconut
milk or change in osmolarity did not result in further
development.
Gamberg et al., in Plant Cell Reports 2, 213 (1983b),
describe the preparation of protoplasts from cell cul-
tures of Glycine tabacina and Glycine soja and from leaf
tissue from the soybean Glycine max cultivar (cv.) Wil-
liams 82. The protoplasts formed cells which could be
induced to form heart-shaped embryos by the proce-
dure of Gamberg et al (1983). As in the latter reference,
no plantlets were formed from the procedure.
Christianson et al, in Science 222, 632 (1983a), disclose
the regeneration of a plantlet from cell suspension cul-
ture of the soybean Glycine max (L.) Merrill cv. Mitch-
ell. This appears to have been the result of a random
even and appears to have resulted from a piece of clonal
tissue. Immature embryos were aseptically removed
from 2.5-3.0 cm pods, and embryo axes were cut into
1-2 mm pieces. These pieces were placed on a solid
medium to induce callus formation. This medium con-
sisted of MS salts, 0.5 mg/I nicotinic acid, 0.5 mg/I
pyridozine, 100 mg/l thiamine, 100 mg/I inositol, 2%
sucrose and 5 mg/l 2,4-D. The hard, non-friable tissue
was selected for transfer to new medium and resulted in
a tissue line that gave rise to hard, green, glossy, abnor-
mal embryos. When the callus tissue was transferred
from the induction medium to a N-amended medium
and then transferred back to the induction medium, one
exceptional piece of tissue was obtained which was
covered with small embryoids. The N-amended me-
dium consisted of the induction medium in which the
two nitrogen salts of the MS salts were replaced with 20
mM ammonium citrate. Transfer of the embryoids to a
medium containing 0.005 mg/I IBA and 0.2 mg/I BA
gave rise to shoot formation. Transfer of the shoots to a
basal medium containing 0.1 mg/1 of !AA resulted in
root formation to produce plantlets. This procedure
does not appear to be generally applicable for regener-
ating soybean cultivars, but instead appears to have
been a random event which may not be reproducible.
Support for this analysis lies in Christianson et al.'s
3
4,837,152
4
source of the embryogenic tissue. Christianson et aL
state that "one exceptional piece of tissue" with embry-
oids was obtained. Since only one was obtained out of
many initiated, it implies that this regeneration ·was a
random even and could have been clonal in nature. 5
(d) rooting the germinated embryoids by subcultur-
ing on a fourth medium comprising mineral salts, vita-
mins, sucrose and optionally a hormone selected from
the group consisting of IAA and IBA.
In a second embodiment, the process comprises the
steps of: -Copending application Ser. No. 356,222 discloses a
method for regenerating several cultivars of soybean
(Glycine max). In the process described in that applica-
tion, an immature embryo is cultured in the light on a
first medium which contains either 2,4-D, a mixture of
2,4-D and IAA, or a mixture of2,4-D, IAA and ABA as
the hormone to induce callus formation and embryoid
formation from the callus. The embryoids are matured
(a) inducing pre-callus formation from tissue of a
soybean plant by culturing on a first medium compris-
ing mineral salts, vitamins, 2,4-D and optionally amino
10 acids;
by culturing them on a second medium which is se-
lected from a group of five media. The mature embry-
oids are then cultured on a third medium to induce
shoot formation. The hormone utilized in the third me-
dium may be a mixture of IBA and BA, a mixture of
IAA and adenine sulfate, a mixture of IBA, BA and
GA3, or a mixture of IAA, BA and GA3. Shoots are
transferred to a fourth medium which is either hor-
mone-free or contains the hormone IAA or IBA to
induce the formation of roots.
·· · (b) completing the formation of callus, and forming
embryoids and partially maturing the embryoids by
subculturing on a second medium comprising mineral
salts, vitamins, sucrose, a mixture of 2,4-D, ABA and
15 IAA and optionally amino acids;
(c) further maturing the embryoids by subculturing
on a liquid third medium comprising mineral salts, vita-
mins, sucrose, amino acids and a mixture of 2,4-D and
ABA;
20 (d) germinating the embryoids by subculturing on a
fourth medium comprising mineral salts, vitamins, su-
crose and a hormone selected from the group consisting
of a mixture of NAA, BA, t-zeatin and kinetin, a mix-
ture of IAA, kinetin, ABA and GA3 and a mixture of
BA and IBA; and
(e) rooting the germinated embryoids by subculturing
on a fifth medium comprising mineral salts, vitamins,
sucrose and optionally a hormone selected from the
group consisting of IBA and IAA.
Ranch, J.P., et al., In Vitro Cell Develop. Boil 21, 653
(1985) discloses a method for regenerating several culti- 25
vars of soybean. In this process, callus tissue is initiated
and somatic embryos formed by culturing immature
embryos in the light (50 lux) on a first medium. which
contains 2,4-D. The somatic embryos are matured in the
dark by culturing on a medium which contains IBA or 30 The soybean donor tissue may also be cultured on a
preconditioning medium prior to culturing on the first
medium in the second embodiment. The pre-condition-
ing medium comprises mineral salts, vitamins, sucrose
and 2,4-D.
a mixture of IBA and ABA as the hormone. The matu-
ration medium is either liquid or solid. The embryos are
germinated by culturing in the light (100 lux) on a me-
dium containing a mixture of IBA and GA3 as the hor-
mone. The young plants are transferred to medium
containing IBA for root development and cultured in
the light (1500 lux).
35 The source of the tissue is preferably immature em-
Soybean plants and seeds are produced by this pro-
cess. The resulting soybean plants may differ from the
starting plant material as a result of somoclonal varia- 40
tion. The pathway is also useful in that it will enable the
use of various selection processes to provide further
variation. Plants which are produced can be used in
conventional breeding programs.
bryos from cultivars of Glycine max (L.) Merrill. Suit-
able cultivars include Williams 82, Corsoy 79, Forrest,
Mitchell 450, Beeson 80, Miami, Century 84, Evans,
Gnome, and Northrup King variety 5-18-84-8032-23.
DETAILED DESCRIPTION OF THE
INVENTION
The present invention is directed to an improved
process for regenerating soybeans (Glycine max)
SUMMARY OF THE INVENTION
45 through the use of cell or tissue culture. In this process,
regenerated soybean plantlets are obtained which can
be placed in soil and grown to maturation. The present
invention is also directed to soybean plants obtained by
The process of the present invention comprises the
steps of inducing callus and embryoid formation from
tissue of a soybean plant, maturing the embryoids, ger-
minating the embryoids, and forming roots on the ger- 50
minated embryoids.
More specifically, in one embodiment, the present
process comprises the steps of:
(a) inducing callus and embryoid formation from
tissue of a soybean plant by culturing on a first medium 55
comprising mineral salts, vitamins, sucrose, 2,4-D, and
optionally ABA and/or amino acids;
(b) maturing the embryoids by subculturing on a
second medium comprising mineral salts, vitamins, su-
crose and a hormone selected from the group consisting 60
of a mixture of IAA and t-zeatin and a mixture of IAA,
t-zeatin, ABA and picloram; ·
(c) germinating the embryoids by subculturing the
embryoids on a third medium comprising mineral salts,
vitamins, sucrose, a hormone selected from the group 65
consisting of a mixture of IAA, kinetin, ABA and GA3
and a mixture of BA and IBA and optionally amino
acids; and
this process and seeds obtained from these plants.
In general, the process comprises (a) inducing callus
and embryoid formation from donor tissue of a soybean
plant, (b) maturing the embryoids, (c) germinating the
mature embryoids, and (d) forming roots on the germi-
nated embryoids which results in the formation of a
plant or plantlet. Optionally, in one embodiment, the
soybean donor tissue can be first pre-conditioned before
being placed into this process. Each of the media uti-
lized in this process contain mineral salts, vitamins and
sucrose. In addition, each medium contains a different
scheme of hormones to accomplish the desired result,
i.e., plant regeneration.
The plant donor tissue which is preferred for use in
the initiation of callus and embryoid formation is the
immature embryo. The immature embryos are isolated
from pods which are periodically harvested from the
soybean plant. Pods are usually harvested when they
reach the size of 1.5-2.5 cm in length. The pods are
surface-sterilized and the embryos are removed asepti-
5
4,837,152
6
cally. The embryos are 0.5-7 mm in length. It is pre-
ferred to use embryos that are 1-4 mm in length. If the
embryos are smaller than l mm, they must be matured
before being plated onto the first medium. Embryos can
be matured as described in copending application Ser. 5
No. 635,222.
At least two embodiments can be utilized to regener-
ate soybeans in accordance with the present invention.
The first embodiment is slower than the second, espe-
cially through the steps of callus induction, embryoid IO
formation and embryoid maturation. Each embodiment
will be described separately.
In the first step of the first embodiment, the immature
embryo is cultured to induce callus and embryoid for-
mation. This is accomplished by culturing the immature 15
embryos on a first medium A.
The first medium A comprises mineral salts, vitamins
and sucrose. The mineral salts comprise macroelements
and microelements. The macroelements used in the first
medium may be the following compounds: magnesium 20
sulfate, calcium chloride, monopotassium phosphate,
potassium nitrate and ammonium nitrate. The microele-
ments contained in the first medium A are: boric acid,
manganese sulfate, zinc sulfate, sodium molybdate (VI),
copper (II) sulfate, cobalt chloride, potassium, iodide, 25
iron (II) sulfate and disodiuni EDTA.
The preferred amounts of the macroelements and
microelements used to prepare one liter of the first
medium A are as follows: 370 mg magnesium sulfate
heptahydrate, 440 mg calcium chloride dihydrate, 170 30
mg monopotassium phosphate, 1900 mg potassium ni-
trate, 1650 mg ammonium nitrate, 6.2 mg boric acid,
16.9 mg manganese sulfate monohydrate, 8.6 mg zinc
sulfate heptahydrate, 0.25 mg sodium molybdate (VI)
dihydrate, 0.025 mg copper (II) sulfate pentahydrate, 35
0.025 mg cobalt chloride hexahydrate, 0.83 mg potas-
sium iodide, 41.7 mg iron (II) sulfate heptahydrate, and
55.9 mg disodium EDTA. This combination of mineral
salts is known in the art as the MS mineral salts, which
has been modified so that the medium contains more 40
iron and EDTA, one and one-half times more than the
standard MS mineral salts.
The first medium A also contains vitamins. The vita-
mins used include nicotinic acid, glycine, pyridoxine,
thiamine, folic acid and biotin. These vitamins are 45
known in the art as Nitsch's vitamins. The Nitsch's
vitamins have been modified so that they contain more
thiamine, and optionally less nicotinic acid. In addition
to these vitamins, the first medium also contains myo-
inositol. The amount of myoinositol utilized may be 100 50
mg/I, 1,500 mg/l or 1,600 mg/l.
The preferred amounts of vitamins used to prepare
one liter of the first medium A are as follows: 5 mg
nicotinic acid, 2 mg glycine, 0.5 mg pyridoxine hydro-
chloride, 0.9 mg thiamine hydrochloride, 0.5 mg folic 55
acid and 0.05 mg biotin. This vitamin mixture will be
referred to herein as modified Nitsch's vitamins A, and
is preferred in the first medium. It is also possible to
utilize modified Nitsch's vitamins B. This vitamin mix-
ture is identical except that 10.4 mg/I thiamine hydro- 60
chloride and 0.5 mg/l nicotinic acid are used. A third
vitamin mixture may also be used, which will be re-
ferred to herein as modified Nitsch's vitamins C. This
vitamin mixture is identical to modified Nitsch's vita-
mins A, except that 10.4 mg/I thiamine hydrochloride is 65
used.
The first medium A contains 2%-3% sucrose, prefer-
ably 2%, and a gelling substance such as agar or Gelrite
(trademark, Kelco Commercial Development). It is
preferred to use Gelrite at a concentration of0.2%. The
medium has a pH of 5.5-6.0 with a preferred pH of 5.8.
In addition to the above components, the first me-
dium A also contains 2,4-D as the hormone. 2,4-D is
generally present in the first medium A at a concentra-
tion of about 5 mg/I to about 10 mg/I. It is preferred to
use 5 mg/12,4-D in the first medium A. Optionally, first
medium A also contains ABA at a concentration of
about 0.0264 mg/I. The first medium may also option-
ally contain amino acids selected from the group con-
sisting of L-glutamine at a concentration of 2.19 g/1 and
a mixture of 800 mg/I L-glutamine, 350 mg/I L-methio-
nine and 200 mg/I L-asparagine. This latter combina-
tion will be referred to herein as amino acids. A. The
first medium A is sterilized by autoclaving all of the
components except the vitamins, amino acids, ABA and
2,4-D which are sterilized by microporous membrane
filtration.
It is preferred to culture to immature embryo on the
first medium for about 25 to about 35 days before trans-
ferring to the second medium. Culturing on the first
medium is conducted in the light, such as a Grow-Lux
fluorescent light or a cool white fluorescent light, with
a photoperiod of 16 hours, at a temperature of 25°-29°
c.
After culturing the immature embryo on the first
medium, the callus with embryoids is subcultured on a
second medium to mature the embryoid. The callus
with the embryoids is subcultured on the second me-
dium in the light for 20-45 days, preferably for about
25-35 days per subculture, to mature the embryoids. It
may be necessary to transfer the maturing embryoids to
fresh medium during this time period in order to obtain
complete maturation. The maturing embryoids are
transferred based on their morphological appearance,
i.e., their similarity to natural zygotic embryos. Any
second medium may be utilized for the transfer.
The second medium may be selected from a group
consisting of three different media. Each second me-
dium contains 2% to 3%, preferably 2%, sucrose and a
gelling substance, preferably Gelrite. In addition to
these components, the second medium may also contain
1,000-4,000 mg/I mannitol. The pH is 5.5-6.0, prefera-
bly 5.8. Each medium is sterilized by autoclaving except
the vitamins and hormones, which are filter-sterilized.
Second medium A comprises mineral salts, vitamins,
casein hydrolysate and a hormone. The mineral salts are
the same as in the first medium, except that 4.524 g of
ammonium citrate and 1.010 g of KN03 are utilized in
place of 1.65 g of ammonium nitrate and 1.9 g of KN03.
This composition will be referred to as mineral salts A.
The vitamins are the same as in the first medium, prefer-
ably modified Nitsch's vitamins A. 100 mg/I of myoino-
sitol is preferably used. Preferably 100 mg/I of casein
hydrolysate is utilized, as is 0.4% Gelrite. The hormone
which is utilized is a mixture of IAA, t-zeatin, ABA and
picloram. It is preferred to use about 1.0 mg/I IAA,
about 1.0 mg/I t-zeatin, about 0.0264 mg/I ABA, and
about 0.0096 mg/I picloram.
Second medium B comprises the same mineral salts
and vitamins as in the first medium. It is preferred to use
modified Nitsch's vitamins A. 100 mg/I of myoinositol
is preferably used. The hormone which is utilized in
second medium B is a mixture of IAA and t-zeatin,
preferably at a concentration of about 1 mg/I IAA and
0.5 mg/I t-zeatin.
7
4,837,152
8
Second medium C comprises mineral salts, vitamins,
casein hydrolysate and a hormone. The mineral salts are
the same as in the first medium, except that 4.524 g/I of
ammonium citrate is used in place of ammonium nitrate
and KN03. This composition of mineral salts will be 5
referred to as mineral salts B. Myoinositol is preferably
present at 100 mg/I, and 100 mg/I of casein hydrolysate
is used. 0.4 mg/I Gelrite is used in this medium. The
vitamins are the same as in the first medium, preferably
modified Nitsch's vitamins A. The hormone which is 10
utilized is the same as in second medium A.
In this embodiment, the most preferred second me-
dium is second medium C, with second medium B being
the next preferred medium.
After maturing the embryoids, the third step is to 15
germinate the embryoids by transferring and subcultur-
ing them on a germinating medium, hereinafter referred
to as the third medium. The embryoids are subcultured
on the third medium in the light for 20-45 days, prefera-
bly for about 25-35 days per subculture. It may be nee- 20
essary to transfer the material to fresh medium during
this time period. Iftransfers are made, they may be done
after 20-45 days, preferably after 30 days. Transferring
is usually done if the shoots have not elongated prop-
erly. That is, ifthe shoots do not have two sets ofleaves, 25
they are transferred to fresh third medium or onto a
modified third medium containing one-half the concen-
tration of the macroelements other than iron or one-half
the concentration of all of the mineral salts except for
iron, with the other components being the same, before 30
they are placed on the fourth medium. It is preferred to
use one or more subcultures on modified third medium
B, as described further below, if additional transfers are
necessary.
The third medium which can be utilized to germinate 35
the embryoids may be selected from a group consisting
of two different media, hereinafter referred to as third
medium A or B. Each third medium contains 2%-3%,
preferably 2%, sucrose and a gelling substance, prefera-
bly 0.2% Gelrite. The pH is 5.5-6.0, preferably 5.8. 40
Each medium is sterilized by autoclaving, except that
the vitamins, hormones and amino acids are sterilized
by membrane filtration.
Third medium A comprises mineral salts, vitamins,
amino acids and a hormone. The mineral salts are the 45
same as used in the first medium, except that 2 g of
Nf4N03 and 600 mg of KN03 are used. This combina-
tion of mineral salts will be referred to as mineral salts
C. The vitamins which are used include thiamine hy-
drochloride and pyridoxine hydrochloride. THe vita- 50
mins are known in the art as Sussex's vitamins. Sussex's
vitamins are present at 15 mg/I thiamine hydrochloride
and l.5 mg/I pyridoxine hydrochloride. Myoinositol is
preferably present at 1,500 mg/I concentration. The
amino acids which are used include L-glutamine, L- 55
serine and L-asparagine. The mixture of these·vitamins
is known in the art as Sussex's amino acids. Preferred
amounts of these amino acids are 500 mg/I L-glutamine,
100 mg/I L-serine and 100 mg/I L-asparagine. The
hormone which is utilized is a mixture of IAA, kinetin, 60
ABA and GA3. It is preferred to use about 0.01 mg/I
IAA, 0.1 mg/I kinetin, 0.1 mg/I ABA and 0.1 mg/I
GA3.
Third medium B comprises mineral salts, vitamins
and a hormone. The mineral salts and vitamins are the 65
same as used in the first medium. Preferably, modified
Nitsch's vitamins A is utilized, as is 100 mg/I myoinosi-
tol. The hormone which may be utilized is a mixture of
BA and IBA, preferably at a concentration of 0.2 mg/I,
BA, and 0.005 mg/I IBA. In addition, a mineral salt
composition which has the same concentration of mi-
croelements and iron as the first medium, but only one-
half the concentration of the macroelements, can be
used in this medium. Such a combination will be re-
ferred to herein as mineral salts D. Alternatively, a
mineral salt composition which has one-half the con-
centration of all of the mineral salts, except iron, can be
used. Such a combination will be referred to herein as
mineral salts E. These compositions with lower mineral
salt concentrations will be referred to herein as modi-
fied third medium B.
After germinating the embryoids, the fourth step is to
root the germinated embryoids by transferring to a
root-forming medium, hereinafter referred to as the
fourth medium. The shoots are subcultured on the
fourth medium in the light for 20-60 days, preferably
for about 30 days. Due to slow root development, it
may be necessary to transfer the material to fresh me-
dium during this time period. The transfer can be to
fresh fourth medium or to a modified fourth medium A
or C in which all the macroelements, except iron, are
present at one-half the concentration in the original
fourth medium. Alternatively, a mineral salt composi-
tion having one-half the concentration of all of the
mineral salts except iron and EDTA can be used in
modified fourth medium A or C.
The fourth medium which is used to root the germi-
nated embryoids may be selected from a group consist-
ing of three media A-C. Each medium contains
l %-2%, preferably 1%, sucrose and a gelling sub-
stance, preferably 0.2% Gelrite. The pH is 5.5-6.0,
preferably 5.8. Each medium is sterilized by autoclaving
except the vitamins and hormones which are sterilized
by membrane filtration.
Fourth medium A comprises mineral salts and vita-
mins which are the same as in the first medium. It is
preferred to use modified Nitsch's vitamins A. Prefera-
bly, 100 mg/I myoinositol is utilized. No hormone is
present in this medium. It is also possible to utilize min-
eral salts D or mineral salts E in this medium.
Fourth medium B comprises mineral salts, vitamins
and a hormone. The mineral salts are the same as in the
first medium, except that 300 mg/I Nf4H2P04 and 2.5
g KN03 are used in place of the Nf4N03 and KN03.
This combination will be referred to herein as mineral
salts F. Likewise, the vitamins are the same with modi-
fied Nitsch's vitamins A preferred. 100 mg/I myoinosi-
tol and 1% sucrose are present: The hormone is IAA
with a preferred concentration of 0.5 mg/I.
Fourth medium C comprises mineral salts, vitamins
and a hormone. The mineral salts and vitamins are the
same as in fourth medium A, including the use of min-
eral salts D or E. The hormone is either IAA or IBA, at
a concentration of 0.1-0.5 mg/I. Myoinositol is present
at 100 mg/I.
After the roots have formed, the plantlets are ready
to be potted in soil. The plantlets are potted by transfer-
ring the plantlets to soil which is well moistened and
contained in a high humidity chamber. Once the plant-
lets are established, they are removed from the high
humidity chamber, transplanted to soil, and grown to
maturity to produce seeds.
In the second embodiment, the first step comprises
the culturing of the immature embryo on a first medium
B to induce pre-callus formation. Alternatively, the
immature embryo is first cultured on a pre-conditioning
4,837,152
109
medium before culturing on the first medium B. The
pre-conditioning medium is the same as the first medium
A, except that the concentration of 2,4-D is about 1
mg/I to about 2 mg/I. Modified Nitsch's vitamins A is
preferably utilized. The immature embryo is cultured
on a pre-conditioning medium in the dark at room tem-
perature for about 10 to about 21 days, preferably 14
days, before transferring to first medium B.
First medium B comprises mineral salts, vitamins,
sucrose, 2,4-D and optionally amino acids. The mineral
salts are the same as·described for first medium A. The
vitamins are also the same as for first medium A, i.e.,
modified Nitsch's vitamins A, modified Nitsch's vita-
mins B or modified Nitsch's vitamins C. Modified
Nitsch's vitamins A is preferred. Myoinositol is used at
mg/I 2,4-D and 0.0264 mg/I ABA. Myoinositol is pres-
ent at 100 mg/I or 1,600 mg/I, and sucrose at 2%. The
pH is 5.5-6.0, preferably 5.8. It is preferred to use third
medium C without coconut milk and with L-glutamine
5 as the amino acid. The third medium C may also contain
1,000-4,000 mg/I mannitol.
After maturing the embryoids in the third medium C,
the embryoids are germinated by culturing on a fourth
medium. The culturing of the embryoids for germina-
10 tion is generally performed as described above for the
·· ' first --embodiment. It is preferred to first use fourth me-
dium D as the germinating medium with one or more
subcultures on this medium. The germinated embryoids
will be transferred as discussed in the first embodiment,
15 generally to modified third medium B. The recalcitrant
embryoids will preferably be subcultured on fourth
medium E in the light for 7-14 days, and then back to
fourth medium D and cultured as previously described.
a concentration of 100 mg/I or 1,600 mg/I. 2%-3%,
preferably 2%, sucrose and a gelling substance, prefera-
bly 0.2% Gelrite, are present. The hormone is 2,4-D,
preferably at 10 mg/I concentration. The first medium
may optionally contain amino acids, such as L-gluta- 20
mine or a mixture of L-glutamine, L-methionine and
L-asparagine. This latter mixture will be referred to
hereinafter as amino acids A. Preferably 800 mg/I L-
glutamine or a mixture of 800 mg/I L-glutamine, 350
mg/I L-methionine and 200 mg/I L-asparagine is used. 25
The medium has a pH of 5.5-6.0, preferably 5.8. The
medium is sterilized by autoclaving all of the compo-
nents except the vitamins, 2,4-D and amino acids, which
are filter-sterilized. The immature embryo is cultured
The fourth medium which may be utilized for germi-
nating the embryoids is selected from a group consisting
of four different media, herein referred to as fourth
media D-G as discussed above. Each fourth medium
contains 2%-3%, preferably 2%, sucrose and a gelling
substance, preferable 0.2% Gelrite. The pH is 5.5-6.0,
preferably 5.8. Each medium is sterilized by autoclav-
ing, except the vitamins, hormones and amino acids,
which are filter-sterilized.
Fourth medium D comprises mineral salts, vitamins
and a hormone. The mineral salts and vitamins are the
on this medium for about _7-14 days, preferably 7 days,
before transferring to a second medium D. The cultur-
ing is conducted in the light, such as either Grow-Lux
fluorescent light or cool white fluorescent light, with a
photoperiod of 16 hours per day. The pre-callused im-
mature embryo is cultured on second medium D to
complete callus formation, form embryoids, and to par-
tially mature the embryoids. Culturing on the second
medium D is performed in the light as previously de-
scribed for about 14-35 days, preferably for 21 days.
30 same as for first medium B, with modified Nitsch's
vitamins B preferred. In addition, mineral salts D or
one-half concentration of all mineral salts may also be
utilized. Myoinositol is present at 100 mg/I or 1,600
mg/I, and sucrose at 2%. The hormone is a mixture of
35 NAA, BA, t-zeatin and kinetin. The concentrations of
each are preferably 0.05-0.15mg/l NAA. about 0.033
mg/I BA, about 0.033 mg/I t-zeatin, and about 0.033
mg/I kinetin. It is preferred to use 0.15 mg/I NAA. This
Second medium D comprises mineral salts, vitamins, 40
a hormone, and optionally amino acids. The mineral
salts are the same as used in the first medium B. The
vitamins are also the same, but are preferably modified
Nitsch's vitamins B. Myoinositol may be used at a con-
centration of 100 mg/I or 1,600 mg/I. The hormone is a 45
mixture of 2,4-D, IAA and ABA, preferably at a con-
centration of about 3 mg/I 2,4-D, 2 mg/I IAA and
0.0264 mg/I ABA. The amino acids which may option-
ally be present are the same as in the first medium B.
combination of hormones is known in the art as Collins'
germinating hormones.
Fourth medium E is the same as fourth medium D,
except for the hormone concentrations. It is preferred
to use about 0.05 mg/ml NAA, about 0.33 mg/I BA,
about 0.33 mg/I t-zeatin and about 0.33 mg/I kinetin in
fourth medium E. This combination of hormones is also
known as Collins' germinating hormones.
Fourth medium F and fourth medium G are the same
as third medium A and third medium B described above
for the first embodiment.
The next step is to further mature the embryoids by
culturing in a liquid medium, hereinafter referred to as
third medium C. Culturing in this medium is conducted
in the light as previously described for about 7-14 days,
preferably 7 days, with shaking. It is preferred to utilize
baffied flasks for proper aeration and to perform gentle
shaking on a vertical shaker with slow rotation, prefera-
bly 5-10 rpm.
Third medium C comprises mineral salts, vitamins,
amino acids and a hormone. The mineral salts are the
same as in the first medium B. The vitamins are also the
same, but preferably modified Nitsch's vitamins B. The
amino acids may either be L-glutamine at 500-800 mg/I,
amino acids A or a mixture of L-alanine, L-arginine and
L-serine at concentrations of 250 mg/I, 250 mg/I and
100 mg/I, respectively. This mixture will be referred to
as amino acids B. The medium may optionally contain
coconut milk at 0.5% concentration. The hormone is a
mixture of 2,4-D and ABA at a concentration of 0.5
50 Following germination, the shoots are rooted by
culturing on a fifth medium. THe culturing of the
shoots is performed as described above for the first
embodiment. The fifth medium may be selected from a
group of three media, hereinafter referred to as fifth
55 media A-C. Fifth media A, B and C are the same as
fourth media A, B and C, respectively, for the first
embodiment. Plants are transferred to the soil as previ-
ously described.
This process is useful for regenerating plantlets from
60 tissue of many cultivars of soybean. The process is use-
ful for regenerating plantlets from Glycine max (L.)
Merrill cv. Williams 82, Beeson 80, Miami, Century 84,
Forrest, Corsoy 79, Mitchell 450, Evans, Gnome and
Northrup King variety S-18-84-8032023. All cultivars
65 are available commercially or by contacting Dr. Rich-
ard L. Bernard, University of Illinois Department of
Agronomy, Urbana, Ill. 61801 (Northern cultivars) or
by contacting Dr. E. E. Hartwig, U.S. Department of
4,837,152
1211
Agriculture, Agricultural Research Center, Stoneville,
Mo. 38776 (Southern cultivars).
The present invention will be further described by
reference to the following non-limiting examples. In
these examples, culturing in the light refers to culturing
in light having a photoperiod of 16 hours per day at
25°-29° C. unless indicated otherwise. The temperature
during the 8 hour dark phase is 23°-24° C. unless indi-
cated otherwise. In all ofthe media, any one ofthe three
modified Nitsch's vitamins could be used.
EXAMPLE 1
Preparation of Solutions
Component
KH2P04
5 H3B03
FeS04.7H20
-continued
Weight (mg)
850
3J
279.5
Component
KI
CoS04.7H20
Na2 EDTA
E. Mineral Salts F
Weight (mg)
4.J5
O.J25
208.5
A !OX stock solution of mineral salts F was prepared
10 by dissolving the following components in 500 ml of
distilled, deionized water.
Component Weight (mg) Component Weight (mg)
The following stock solutions were prepared for use 15
in making the media described in further detail below.
Nff4H2P04
KN03
CaCJ2.2H20
MgS04'2H20
KH2P04
H3B03
FeS04.7H20
J,500
J2,500
2,200
J,850
MnS04.H20
ZnS04.7H20
Na2Mo04.2H20
CuS04.5H20
84.5
43
1.25
O.J25
4.15
O.J25
1. Mineral Salts
A. MS Minor Salts
A lOOX stock solution of the MS minor salts was 20
prepared by dissolving the following components in 500
ml of distilled, deionized water.
Component Weight (mg) Component Weight (mg)
25
ZnS04.7H20 430 KI 41.5
Na2Mo04.2H20 J2.5 H3B03 310
CuS04.5H20 1.25 MnS04.H20 845
CoCl2.6H20 1.25
850
3J
279.5
KI
CoS04.7H20
Na2 EDTA
2. Vitamins
A. Nitsch's Vitamins A
208.5
A lOOX stock solution of vitamins was prepared by
dissolving the following components in distilled, deion-
ized water of a total volume of 500 ml. The folic acid
was first dissolved in 5 ml of IN KOH before adding it
B. Mineral Salts A 30 to the water.
A !OX stock solution of mineral salts A was prepared,
by dissolving the following components in 500 ml of
distilled, deionized water.
Component Weight (mg) Component Weight (mg)
Component Weight (mg) Component Weight (mg)
nicotinic acid 250 thiamine.HCl 25
glycine JOO folic acid 25
pyridoxine.HCl 25 biotin 2.5
B. Nitsch's Vitamins B
A lOOX stock solution of vitamins was prepared by
N"4 Citrate
KN03
CaCl2.2H20
MgS04.2H20
KH2P04
H3B03
FeS04.7H20
22,620
5,050
2,200
J,850
850
31
279.5
MnS04.H20
ZnS04.7H20
Na2Mo04.2H20
CuS04.5H20
KI
CoS04.7H20
Na2 EDTA
84.5
43
1.25
O.J25
4.J5
0.125
208.5
40 dissolving the following components in distilled, deion-
ized water of a total volume of 500 ml. The folic acid
was first dissolved in 5 ml of IN KOH before adding it
to the water.
C. Mineral Salts B 45
A lOX stock solution of mineral salts B was prepared
by dissolving the following components in 500 ml of
distilled, deionized water.
Component Weight (mg) Component Weight (mg)
N"4 Citrate 22,620 ZnS04.H20 43
CaCl2.2H20 2,200 Na2Mo04.2H20 1.25
MgS04.7H20 1.850 CuS04.5H20 0.125
KH2P04 850 KI 4.J5
H3B03 3J CoS04.7H20 O.J25
MnS04.7H20 84.5 Na2 EDTA 208.5
FeS04.7H20 279.5
D. Mineral Salts C
50
55
A !OX stock solution of mineral salts C was prepared 60
by dissolving the following components in 500 ml of
distilled, deionized water.
Component
nicotinic acid
glycine
pyridoxine.HCI
Weight (mg)
25
100
25
C. Nitsch's Vitamins C
Component
thiamine.HCl
folic acid
biotin
Weight (mg)
500
25
2.5
A IOOX stock solution of vitamins was prepared by
dissolving the following components in distilled, deion-
ized water of a total volume of 500 ml. The folic acid
was first dissolved in 5 ml of IN KOH before adding it
to the water.
Component
nicotinic acid
glycine
pyridoxine.HCI
Weight (mg)
250
JOO
25
D. Sussex's Vitamins
Component
thiamine.HCl
folic acid
biotin
Weight(mg)
500
25
2.5
Component Weight (mg) Component Weight (mg)
----------------------''----~- 65 A lOOX stock solution of Sussex's vitamins was pre-
~~03 1
~:: ~:;g4
4
71:f~ !~·5
pared by dissolving 750 mg of thiamine hydrochloride
CaCJ2 2H2o 2.200 Na2Mo04.m2o 1.25 and 75 mg of pyridoxine hydrochloride in 500 ml of
MgS04.2H20 J.850 CuS04.5H20 0.125 distilled, deionized water.
4,837,152
1413
3. Amino Acids
A. L-Glutamine
An 80 mg/ml stock solution was prepared by dis-
solving 20 g ofL-glutamine in 250 ml of distilled, deion- 5
ized water.
B. Amino Acids A
A stock solution of amino acids A was prepared by
dissolving 20 g of L-glutamine, 8.75 g of I-methionine
and 5 g of L-asparagine in 250 ml of distilled, deionized 10
water.
C. Sussex's Amino Acids
A stock solution of Sussex's amino acids was pre-
pared by dissolving 20 g of L-glutamine, 2.5 g of serine
and 2.5 g of L-asparagine in 250 ml of distilled, deion- 15
ized water.
D. Amino Acids B
A stock solution of amino acids B was prepared by
dissolving 6.25 g of L-alanine, 6.25 g of L-arginine and
2.5 g of L-serine in 250 ml of distilled, deionized water. 20
4. Iron and EDTA
mine hydrochloride, 20 g of sucrose and 2 g of Gelrite
in 800 ml of distilled, deionized water. 5 ml of the iron
and EDTA stock solution were then added. The mix-
ture was brought to the desired volume with distilled,
deionized water, depending on the amount of vitamins
and hormone stock solutions to be added after autoclav-
ing. The final volume when all components were added
was one liter. The pH was adjusted to 5.8 with 1 N HCI
or 1 N NaOH. The mixture was autoclaved at 18 psi for
15 minutes.
10 ml of either modified Nitsch's vitamins A stock
solution, modified Nitsch's vitamins B stock solution, or
modified Nitsch's vitamins C stock solution were filter-
sterilized by passing through a 0.22 micron Millipore
membrane filter and added to the cooling medium. The
appropriate volume of the 2,4-D stock solution, and
optionally the appropriate volume of ABA, was added
after filter-sterilization to give the desired concentra-
tion, i.e., 5-19 mg/I 2.4-D, and optionally 0.0264 mg/I
ABA, to the cooling medium. If amino acids were de-
sired, either 2.19 g!I of L-glutamine were added to the
800 ml of water, or 10 ml of filter-sterilized amino acids
A stock solution was added to the cooling medium. The
A lOOX stock solution of iron and EDTA was pre-
pared by dissolving 1.39 g of iron (II) sulfate heptahy-
drate and 1.86 g of disodium-EDTA in 500 ml of dis-
tilled, deionized water.
25
medium was then poured into petri dishes.
5. Hormones
(A) A 0.264 mg/ml stock solution of ABA was pre-
pared by dissolving 26.4 mg of ABA in 20 ml of IM
30
NaHC03 and diluting to 100 ml with distilled, deionized
water.
2. First Medium B
First medium B was prepared as described above for
first medium A, using 10 mg/1 2,4-D. If first medium B
contained 1,600 mg/I myoinositol, an additional 1.5 g of
myoinositol were also dissolved in the 800 ml of water.
3. Pre-Conditioning Medium(B) A I mg/I stock solution of BA was prepared by
dissolving 100 mg of BA in 20 ml of lN NaOH and
diluting to 100 ml with distilled, deionized water.
(C) A 1 mg/ml stock solution of 2,4-D was prepared
by dissolving 100 mg of 2,4-D in 20 ml of 70% ethanol
and diluting to 100 ml with distilled, deionized water.
Pre-conditioning medium was prepared as described
35 for the first medium, having a concentration of 1.2 mg/I
2,4-D. The medium was poured into petri dishes.
(D) A 1 mg/ml stock solution of IBA was prepared
by dissolving 100 mg of IBA in 20 ml of 70% ethanol
40
and diluting to 100 ml with distilled, deionized water.
9E) A 1 mg/ml stock solution of kinetin was prepared
by dissolving 100 mg of kinetin in 20 ml of IN NaOH
and diluting to 100 ml with distilled, deionized water.
(F) A 1 mg/ml stock solution of t-zeatin was prepared
by dissolving 100 mg of t-zeatin in 5 ml of SN HCI and 45
diluting to 100 ml with distilled, deionized water.
(G) A 0.0025 mg/ml stock solution of picloram was
prepared by dissolving 0.24 mg of picloram in 20 ml of
warm, distilled, deionized water and diluting to 100 ml
with distilled, deioniied water. 50
(H) A 0.1 mg/ml stock solution of IAA was prepared
by dissolving 10 mg ofIAA in 20 ml of70% ethanol and
diluting to 100 ml with distilled, deionized water. The
stock solution was stored in a bottle wrapped in alumi-
num foil in a refrigerator. The solution was prepared 55
fresh every one to two months.
(I) A 1 mM stock solution of GA3 was prepared by
dissolving 34.6 mg of GA3 in 20 ml of absolute ethanol
and diluting to 100 ml with distilled, deionized water.
EXAMPLE 2
Preparation of Media
1. First Medium A
60
The first medium A was prepared by dissolving one 65
packet of Murashige minimal organics solution without
sucrose (Gibco Laboratories Catalog No. 510-3118),
which contained 100 mg myoinositol and 0.4 mg thia-
4. Second Medium
A. Second Medium A
Second medium A was prepared by dissolving 20 g of
sucrose and 4 g of Gelrite, 100 mg of casein hydroly-
sate, and either 100 mg or 1.5 g of myoinositol in 800 ml
of distilled, deionized water. 100 ml of mineral salts A
stock solution were added, and the mixture brought to
the desired volume as described above. The pH was
adjusted to 5.8, and the mixture autoclaved as previ-
ously described. 10 ml of either modified Nitsch's vita-
mins A stock solution, modified Nitsch's vitamins B
stock solution or modified Nitsch's vitamins C stock
solution were filter-sterilized and added to the cooling
medium. The appropriate volumes of the hormone
stock solutions were filter-sterilized and added to the
cooling medium to give the desired concentration, i.e.,
I mg/I IAA, 1 mg/I t-zeatin, 0.0264 mg/ 1 ABA, and
0.0096 mg/I picloram. The medium was poured into
petri dishes.
B. Second Medium B
Second medium B was prepared as described for first
medium A, except that the appropriate amounts of the
IAA and t-zeatin stock solutions were used in place of
2,4-D to give the desired concentration, i.e., I mg/I
IAA and 0.5 mg/I t-zeatin. In addition, 1.5 g of myoino-
sitol were also dissolved in the water, if desired.
C. Second Medium C
Second medium C was prepared as described for
second medium A, except that mineral salts B stock
solution was used and 100 mg of myoinositol were dis-
solved in the water.
4,837,152
1615
D. Second Medium D
Second medium D was prepared as described for first
medium B, except that the appropriate amounts of the
2,4-D, IAA and ABA stock solutions were used in place
of 2,4-D only to give the desired concentrations, i.e, 3 5
mg/I 2,4-D, 2 mg/I IAA, and 0.0264 mg/I ABA. Modi-
fied Nitsch's vitamins B was preferred.
5. Third Medium (Fourth Medium)
A. Third Medium A (Fourth Medium F) 10
Third medium A was prepared by dissolving 20 g of
sucrose, w g of Gelrite, and either 1.5 g or 100 mg of
myoinositol in 800 ml of distilled, deionized water. 100
ml of mineral salts C stock solution was added, and the
volume brought to the desired level as described above. 15
The pH was adjusted to 5.8 and autoclaved as described
above. 10 ml of Sussex's vitamins stock solution, 10 ml
of Sussex's amino acids stock solution and the appropri-
ate volumes of the IAA, kinetin, ABA and GA3 stock
solutions to give the desired concentrations, i.e., 0.01 20
mg/I IAA, 0.1 mg/I kinetin, 0.1 mg/I ABA and 0.1
mg/I GA3, were filter-sterilized and added to the cool-
ing medium, which was then poured into petri dishes.
B. Third Medium B (Fourth Medium G)
Third medium B was prepared as described for first 25
medium A, except that the appropriate amounts of the
BA and IBA stock solutions were used in place of2,4-D
to give the desired concentrations, i.e., 0.2 mg/I BA and
0.005 mg/I IBA. The medium was poured into petri
dishes.
Modified third medium B, having one-half the con-
centration of macroelements except iron, was prepared
as described for first medium A except that only one-
half packet of Murashige medium was dissolved. 50 mg
30
of myoinositol and 0.2 mg of thiamine hydrochloride 35
were also dissolved in the water. 10 ml of the iron and
EDTA stock solution and 5 ml of the MS minor salts
stock solution were also added.
Modified third medium B, having one-half the con-
centration of all mineral salts except iron was prepared 40
as described above except that the MS minor salts stock
solution was not added.
C. Third Medium C
Third medium C was prepared as described for first
medium B, except that no Gelrite was used, either 45
6.25-10 ml of the L-glutamine stock solution, 10 ml of
amino acids A stock solution or 10 ml of the amino acids
B stock solution were used, and the appropriate
amounts of 2,4-D and ABA were used to give the de-
sired concentrations, i.e., 0.5 mg/I 2,4-D and 0.0264 50
mg/I ABA. Modified Nitsch's vitamins B was pre-
ferred. If coconut milk was present, it was added to a
final concentration of 0.5%. The medium was poured
into buffered flasks.
appropriate amount of IAA to give the desired concen-
tration, i.e., 0.5 mg/I, were used. The medium was
poured into petri dishes.
C. Fourth Medium C (Fifth Medium C)
Fourth medium C, including one-half strength mac-
roelements except iron, or all mineral salts except iron
and EDTA, was prepared as described for fourth me-
dium A except that the appropriate amounts of either
the IAA or the IBA stock solution were added to give
the desired concentration, i.e., 0.1-0.5 mg/I.
D. Fourth Medium D
Fourth medium D was prepared as described for first
medium B, except that the appropriate amounts of
NAA, BA, t-zeatin and kinetin stock solutions were
used to give the desired concentrations, i.e., 0.05-0.15
mg/I NAA, 0.033 mg/I BA, 0.033 mg/I t-zeatin and
0.033 mg/I kinetin. Modified Nitsch's vitamins B was
preferred. Modified fourth medium D, having one-half
the concentration of macroelements except iron and
EDTA or of all mineral salts except iron and EDTA,
was prepared analogously to that previously described.
E. Fourth Medium E
Fourth medium E or modified fourth medium E was
prepared as described for fourth medium D, except that
the desired concentrations of hormones were 0.05 mg/I
NAA, 0.33 mg/I BA, 0.33 mg/I t-zeatin and 0.33 mg/I
kinetin.
EXAMPLE 3
Soybean Regeneration
Immature embryos were isolated from pods of the
soybean Glycine max (L.) Merrill cv. Corsoy 79 or
Mitchell 450, when the pods were 1.5 to 5.0 cm in
length. The soybean pods were collected each morning
and placed in a sterile 18 oz. bottle. Surface-sterilizing
agents employed separately were as follows: 70% etha-
nol (1 min.), 15% concentrated Clorox TM and 0.1 %
Tween 80 (8 min.), and washing three times with dis-
tilled, deionized water. Sterile pods were placed in the
top of a sterile petri dish (100 mm X25 mm). Each pod
was individually cut with scissors. The ovules (two to
three per pod) were carefully pressed out of the pod
into the bottom petri dish (sterile). A pair of forceps and
a needle probe were used to remove the immature em-
bryo from each ovule. The embryos were plated onto
the first medium A contained in a petri dish. First me-
dium A contained 10 mg/I 2,4-D, 0.0264 mg/I ABA,
2.19 g/1 L-glutamine and modified Nitsch's vitamins A.
The petri dish was placed in the light (cool white) and
cultured for 28 days to form calli and embryoids.
At this time, each callus with embryoids was trans-
ferred to second medium C and cultured on this me-
dium for 28 days in the light (cool white). The callus
6. Fourth Medium
A. Fourth Medium A (Fifth Medium A)
Fourth medium A was prepared as described for first
medium A, except that only 10 g of sucrose were used
and 2,4-D was excluded. The medium was poured into
petri dishes. Fourth medium A, having one-half the
concentration of macroelements except iron, or of all
mineral salts except iron, was prepared analogously to
that described for third medium B.
55 with mature embryoids was then transferred to a third
medium B and cultured on this medium for 28 days in
the light (cool white). The germinating embryos were
transferred to modified third medium B containing one-
half concentration of all mineral salts except iron and
B. Fourth Medium B (fifth Medium B)
Fourth medium B was prepared as described for
second medium A, except that 10 g of sucrose, 2 g of
Gelrite, 100 ml of mineral salts F stock solution and the
60 EDTA and cultured for 28 days in the light (cool
white). The germinating embryos were again trans-
ferred to this medium and cultured an additional 28
days. The germinated embryoids were then transferred
to fourth medium B. The shoots were cultured on this
65 medium for 28 days in the light (cool white). During
this time, the shoots formed roots.
The Gelrite was washed off the roots of the plantlets
with sterile, distilled, deionized water. The plantlets
4,837,152
1817
for 41 days in the light (cool white). The callus with
mature embryoids-was then transferred to third medium
A and cultured in the light. The germinating embryos
are cultured and transferred as described in Example 3
were then transferred to soil in a quart Mason jar. The
bottom of the Mason jar was covered with sterile, acti-
vated charcoal. Four inches of an autoclaved, equal
mixture of vermiculite, Perlite and potting soil were
placed over the charcoal The plantlets were planted in
the soil and the soil was well moistened with sterile,
distilled, deionized water. Parafilm TM was placed over
the jar and the cap was screwed over the Parafilm. The
jar was then placed in a Percival growth chamber at 24°
5 to produce plants, except that only the macroelements,
except iron and EDTA, are at one-half concentration in
modified third medium B.
C., having a photoperiod of 16 hours per day. After 12 10
days, the jar was removed ·from the growth chamber
and placed in a sweater box in the greenhouse. A second
sweater box was placed perpendicular to and over the
first sweater box and a paper towel was placed over it to
provide for diffuse sunlight. The greenhouse maintained 15
a temperature of 29° C.±3° C. during the day and 21°
C.±2° C. during the night, and a photoperiod of 16
hours per day. After one week, the Parafilm was re-
moved from the jar. Four days later, the regenerated
plants were transplanted to a 6" pot containing an equal 20
mixture of vermiculite, perlite and potting soil, and
returned to the sweater boxes. The regenerated plant
flowered and formed pods which contained developing
ovules.
EXAMPLE IO
Soybean plants are regenerated as described in Exam-
ple 9, except that the embryos were cultured on first
medium A for 28 days, second medium C and third
medium B were utilized, and the callus with embryoids
was cultured on second medium C for 31 days.
EXAMPLE 11
Soybean plants are regenerated as described in Exam-
ple 10, except that second medium B was used in place
of second medium C.
EXAMPLE 12
EXAMPLE4
Soybean Regeneration
Soybean plants were regenerated from immature
embryos as described in Example 3, except that second
medium A was used in place of second medium C.
Immature embryos were isolated from the Corsoy 79
cultivar as described in Example 3, plated on first me-
dium B containing 10 mg/I 2,4-D, and cultured in the
25 light (Grow-Lux). After 8 days, the pre-callus wa5
transferred to second medium D and cultured in the
light (Grow-Lux) for 19 days. The callus was maturing
embryoids was then placed in third medium C, which is
EXAMPLE 5
30
a liquid and cultured in the light (Grow-Lux) with gen-
tle shaking for 13 days. The callus with mature embry-
oids was then transferred to fourth medium D having
0.15 mg/I NAA and cultured in the light (Grow-Lux)
for 29 days. The embryoids were transferred to fourth
Immature embryos were isolated from the Corsoy 79
cultivar as described in Example 3, plated on first me-
dium A containing 5 mg/I 2,4-D, and cultured in the 35
light (cool white). After 28 days, the callus with embry-
oids was transferred to second medium A and cultured
for 30 days in the light (cool white). The callus with
mature embryoids was then transferred to third medium
B and cultured in the light (cool white). The germinat- 4-0
ing embryos are cultured and transferred as described in
Example 3 to produce plants, except that only the mac-
roelements, except iron and EDTA, are at one-half
concentration in modified third medium B.
medium D having 0.15 mg/I NAA and cultured in the
light (Grow-Lux). The germinating embryoids are cul-
tured on and transferred from fourth medium D as
described in example 3, i.e., to modified fourth medium
G and then to fifth medium for germination and root
formation, except that the light is grow-Lux and only
the macroelements, except iron and EDTA, are at one-
half concentration in modified fourth medium G. Em-
bryoids which have not germinated on fourth medium
Dare cultured on fourth medium E for 70-14 days, and
EXAMPLE6
45 then returned to fourth medium D and cultured as
above.
EXAMPLE 13
Immature embryos were isolated from the Williams
Soybean plants are regenerated as described in Exam-
ple 5, except that second medium C was used in place of
second medium A, and culturing on this medium was
for 24 days.
EXAMPLE 7
50 82 cultivar as described in Example 3, plated on first
medium B containing IO mg/12,4-D, and cultured in the
light (cool white). After 14 days, the pre-callus was
transferred to second medium D and cultured in theSoybean plants are regenerated as described in Exam-
ple 6, except that third medium A was used in place of
third medium B, and culturing on second medium.B was 55
for 28 days.
EXAMPLE 8
Soybean plants are regenerated as described in Exam-
ple 7, except that second medium B was used in place of 60
second medium C.
light (cool white) for 14 days. The callus with maturing
embryoids was then placed in third medium C, which is
a liquid, and cultured in the light (cool white) for 13
days. The callus with mature embryoids was then trans-
ferred to fourth medium D having 0.15 mg/I NAA and
cultured in the light (cool white) for 29 days. The em-
bryoids were transferred to fourth medium D having
0.15 mg/I NAA and cultured in the light (Grow-Lux).
The germinating embryoids are cultured on and trans-
EXAMPLE 9 ferred from fourth medium D as described in Example
Immature embryos were isolated from the Williams 3, i.e., to modified fourth medium G and then to fifth
82 cultivar as described in Example 3, plated on first 65 medium for germination and root formation, except that
medium A containing 5 mg/I 2,4-D, and cultured in the only the macroelements, except iron and EDTA, are at
light (cool white). After 18 days, the callus with embry- one-half concentration in modified fourth medium G.
oids was transferred to second medium A and cultured Embryoids, which have not germinated on fourth me-
19
4,837,152
20
dium Dare cultured on fourth medium E for 7-14 days,
and then returned to fourth medium D and cultured as
above.
While the invention has been described in connection
with specific embodiments thereof, it will be under- 5
stood that it is capable of further modifications. This
application is intended to cover any variations, uses or
adaptations of the invention following, in general, the
principles of the invention and including such depar-
tures from the present disclosure as come within known 10
and customary practice within the art. to which the
invention pertains.
What is claimed is:
1. A process for regenerating soybean plants via so-
matic embryogenesis which comprises: 15
(a) culturing a soybean embryo on a solid first me-
dium which comprises MS mineral salts modified
to contain 41.7 mg/I iron sulfate heptahydrate
(ISH) and 55.9 mg/I disodium ethylenediamine
tetracetic acid (Na2EDTA), vitamins selected from 20
the group consisting of Nitsch's vitamins modified
to contain 10.4 mg/I thiamine hydrochloride and
0.5 mg/I nicotinic acid and Nitsch's vitamins modi-
fied to contain 10.4 mg/l of thiamine hydrochlo-
25
ride, 2%-3% sucrose, .myoinositol and 5-10 mg/I
2,4-dichlorophenoxyacetic acid (2,4-D) in the light
for 25-45 days to induce callus and embryoid for-
mation;
(b) subculturing the callus and embryoids on one or 30
more solid second media which are selected from
the group consisting of:
(i) second medium A, which comprises MS mineral
salts modified to contain no ammonium nitrate,
4,524 mg/I ammonium citrate, 1,010 mg/I potas- 35
sium nitrate, 41.7 mg/I ISH and 55.9 mg/l
Na2EDTA, vitamins selected from the group
consisting of Nitsch's vitamins modified to con-
tain 10.4 mg/I thiamine hydrochloride and 0.5
mg/l nicotinic acid and Nitsch's vitamins modi- 40
fied to contain 10.4 mg/I of thiamine hydrochlo-
ride, 2%-3% sucrose, 100 mg/l casein hydroly-
sate, myoinositol, 1 mg/I indoleacetic acid
(IAA), 1 mg/I t-zeatin, 0.0264 mg/l abscisic acid
(ABA) and 0.0096 mg/I picloram; 45
(ii) second medium B, which comprises MS min-
eral salts modified to contain 41.7 mg/I ISH and
55.9 mg/I Na2 EDTA, vitamins selected from
the group consisting of Nitsch's vitamins modi-
fied to contain 10.4 mg/I thiamine hydrochloride 50
and 0.5 mg/I nicotinic acid and Nitsch's vitamins
modified to contain 10.4 mg/I ofthiamine hydro-
chloride, 2%-3% sucrose, myoinositol, 1 mg/I
IAA and 0.5 mg/I t-zeatin; and
(iii) second medium C, which comprises MS min- 55
era! salts modified to contain no ammonium ni-
trate, no potassium nitrate, 4,524 mg/I ammo-
nium citrate, 41.7 mg/I ISH, and 55.9 mg/I
Na2EDTA, vitamins selected from the group
consisting of Nitsch's vitamins modified to con- 60
tain 10.4 mg/l thiamine hydrochloride and 0.5
mg/I nicotinic acid and Nitsch's vitamins modi-
fied to contain 10.4 mg/I of thiamine hydrochlo-
ride, 2%-3% sucrose, 100 mg/1 casein hydroly-
sate, myoinositol, 1 mg/I IAA, 1 mg/I t-zeatin, 65
0.0264 mg/I ABA and 0.0096 mg/I picloram
in the light for 20-45 days per subculture, to mature
the embryoids;
(c) subculturing the mature embryoids on one or
more solid third media which are selected from the
group consisting of:
(i) third medium A, which comprises MS mineral
salts modified to contain 2,000 mg/I ammonium
nitrate, 600 mg/I potassium nitrate, 41.7 mg/I of
ISH and 55.9 mg/I Na2EDTA, Sussex's vita-
mins, Sussex's amino acids, 2%-3% sucrose,
myoinositol, 0.01 mg/I IAA, 0.1 mg/I kinetin,
0.1 mg/l ABA and 0.1 mg/I gibberellic acid
(GA3); and
(ii) third medium B, which comprises MS mineral
salts modified to contain 41.7 mg/I ISH and 55.9
mg/I Na2EDTA, vitamins selected from the
group consisting of Nitsch's vitamins modified to
contain 10.4 mg/I thiamine hydrochloride, and
0.5 mg/I nicotinic acid and Nitsch's vitamins
modified to contain 10.4 mg/I ofthiamine hydro-
chloride, 2%-3% sucrose, myoinositol, 0.2 mg/I
benzyl adenine (BA) and .0.005 mg/I indole-3-
butyric acid (IBA)
in the light for 20-45 days for subculture, to induce
shoot formation; and
(d) subculturing the shoots on one or more solid
fourth media which are selected from the group
consisting of:
(i) fourth medium A, which comprises MS mineral
salts modified to contain 41.7 mg/I ISH and 55.9
mg/I Na,,EDTA, vitamins selected from the
group consisting of Nitsch's vitamins modified to
contain 10.4 mg/I thiamine hydrochloride, and
0.5 mg/I nicotinic acid and Nitsch's vitamins
modified to contain 10.4 mg/I of thiamine hydro-
chloride, 1%-2% sucrose and myoinositol;
(ii) fourth medium B, which comprises MS mineral
salts modified to contain no ammonium nitrate,
300 mg/I N~2P04, 2,500 mg/I potassium
nitrate, 41.7 mg/I ISH and 55.9 mg/I Na2EDTA,
vitamins selected from the group consisting of
Nitsch's vitamins modified to contain 10.4 mg/I
thiamine hydrochloride and 0.5 mg/I nicotinic
acid and Nitsch's vitamins modified to contain
10.4 mg/I of thiamine hydrochloride, 1%-2%
sucrose, myoinositol and 0.5 mg/I IAA, and;
(iii) fourth medium C, which comprises MS min-
eral salts modified to contain 41.7 mg/I ISH and
55.9 mg/l Na2EDTA, vitamins selected from the
group consisting of Nitsch's vitamins modified to
contain 10.4 mg/I thiamine hydrochloride and
0.5 mg/l nicotinic acid and Nitsch's vitamins
modified to contain 10.4 mg/I of thiamine hydro-
chloride, 1%-2% sucrose, myoinositol and a
hormone selected from the group consisting of
0.1--0.5 mg/I IAA and 0.1--0.5 IBA
in the light for 20-45 per subculture, to·induce root
formation whereby plants are obtained.
2. The process of claim 1 wherein the MS mineral
salts of the third medium B, fourth medium A and
fourth medium C are further modified to contain one-
half the concentration of the macroelements.
3. The process of claim 1 wherein the MS mineral
salts of the third medium B, fourth medium A and
fourth medium C are further modified to contain one-
half the concentration of all the mineral salts except iron
and EDTA.
4. The process of claim 1 wherein the concentration
of myoinositol in third medium A is 1,500 mg/I and in
all other media is I00 mg/I.
4,837,152
2221
5. The process of claim 2 wherein the concentration
of myoinositol in third medium A is 1,500 mg/I and in
all other media is l00 mg/I.
6. The process of claim 3 wherein the concentration
of myoinositol in third medium A is 1,500 mg/I and in 5
all other media is 100 mg/I.
7. The process of claim 1 wherein the vitamins in
third medium A is Sussex's vitamins and the vitamins in
all other media is Nitsch's vitamins modified to contain
10.4 mg/I thiamine hydrochloride and 0.5 mg/I nico- 10
tinic acid.
8. The process of claim 1 wherein the vitamins in
third medium A is Sussex's vitamins and the vitamins in
all other media is Nitsch's vitamins modified to contain
10.4 mg/I thiamine hydrochloride and 0.5 mg/I nico- 15
tinic acid.
9. The process of claim 3 wherein the vitamins in
third medium A is Sussex's vitamins and the vitamins in
all other media is Nitsch's vitamins modified to contain
10.4 mg/I thiamine hydrochloride and 0.5 mg/I nico- 20
tinic acid.
10. The process of claim 4 wherein the vitamins in
third medium A is Sussex's vitamins and the vitamins in
all other media is Nitsch's vitamins modified to contain
10.4 mg/I thiamine hydrochloride and 0.5 mg/I nico- 25
tinic acid.
11. The process of claim 5 wherein the vitamins in
third medium A is Sussex's vitamins and the vitamins in
all other media is Nitsch's vitamins modified to contain
10.4 mg/I thiamine hydrochloride and 0.5 mg/I nico- 30
tinic acid.
12. The process of claim 6 wherein the vitamins in
third medium A is Sussex's vitamins and the vitamins in
all other media is Nitsch's vitamins modified to contain
10.4 mg/ thiamine hydrochloride and 0.5 mg/I nicotinic 35
acid.
13. A process for regenerating soybean plants via
somatic embryogenesis which comprises:
(a) culturing a soybean embryo on a solid first me-
dium which comprises MS mineral salts modified 40
to contain 41.7 mg/I iron sulfate heptahydrate
(ISH) and 55.9 mg/I disodium ethylenediamine
tetracetic acid (Na2EDTA), vitamins selected from
the group consisting of Nitsch's vitamins modified
to contain 10.4 mg/I thiamine hydrochloride and 45
0.5 mg/I nicotinic acid and Nitsch's vitamins modi-
fied to contain 10.4 mg/I of thiamine hydrochlo-
ride, 2%-3% sucrose, myoinositol and about 10
mg/I 2,4-dichlorophenoxyacetic acid (2,4-D) in the
light for about 7-14 days to induce pre-callus for- 50
mation;
(b) subculturing the pre-callus on a solid second me-
dium which comprises MS mineral salts modified
to contain 41.7 ISH and 55.9 mg/I Na2EDTA,
vitamins selected from the group consisting of 55
Nitsch's vitamins modified to contain 0.9 mg/I
thiamine hydrochloride, Nitsch's vitamins modi-
fied to contain 10.4 mg/I thiamine hydrochloride
and 0.5 mg/I nicotinic acid and Nitsch's vitamins
modified to contain 10.4 mg/I of thiamine hydro- 60
chloride, 2%-3% sucrose, myoinositol, 3 mg/I
2,4-D, 2 mg/I indoleacetic acid (IAA) and 0.0264
mg/I abscisic acid (ABA) in the light for about 14
to about 35 days, to complete callus formation and
embryoid formation and partial embryoid matura- 65
tion;
(c) subculturing the embryoids in a liquid third me-
dium which comprises MS mineral salts modified
to contain 41.7 mg/I ISH and 55.9 mg/I
Na2EDTA, vitamins selected from the group con-
sisting of Nitsch's vitamins modified to contain 0.9
mg/I thiamine hydrochloride, Nitsch's vitamins
modified to contain 10.4 mg/I thiamine hydrochlo-
ride and 0.5 mg/I nicotinic acid and Nitsch's vita-
mins modified to contain 10.4 mg/I of thiamine
hydrochloride, an amino acid selected from the
group consisting of 500-800 mg/I L-glutamine, a
mixture of 800 mg/I L-glutamine, 350 mg/I L-
methionine and 200 mg/I L-asparagine and a mix-
ture of 250 mg/I L-alanine, 250 mg/I L-arginine
and 100 mg/IL-serine, 2%-3% sucrose, myoinosi-
tol, 0.5 mg/I 2,4-D and 0.0264 mg/I ABA in the
light for about 7-14 days, to complete the matura-
tion of the embryoids;
(d) subculturing the mature embryoids on a solid
fourth medium selected from the group consisting
of:
(i) fourth medium A, which comprises MS mineral
salts modified to contain 41.7 mg/I ISH and 55.9
mg/I Na2EDTA, vitamins selected from the
group consisting ofNitsch's vitamins modified to
contain 0.9 mg/I thiamine hydrochloride,
Nitsch's vitamins modified to contain 10.4 mg/I
thiamine hydrochloride and 0.5 mg/I nicotinic
acid and Nitsch's vitamins modified to contain
10.4 mg/I of thiamine hydrochloride, 2%-3%
sucrose, myoinositol, 0.05-0.15 mg/I a-naph-
thaleneacetic acid (NAA), 0.033 mg/I ben-
zyladenine (BA), 0.033 mg/I t-zeatin and 0.033
mg/I kinetin;
(ii) fourth medium B, which comprises MS mineral
salts modified to contain 41.7 mg/I ISH and 55.9
mg/I Na2EDTA, vitamins selected from the
group consisting of Nitsch's vitamins modified to
contain 0.9 mg/I thiamine hydrochloride,
Nitsch's vitamins modified to contain 10.4 mg/I
thiamine hydrochloride and 0.5 mg/I nicotinic
acid and Nitsch's vitamins modified to contain
10.4 mg/I of thiamine hydrochloride, 2%-3%
sucrose, myoinositol, 0.05 mg/I NAA, 0.33 mg/I
benzyladenine (BA), 0.33 mg/I t-zeatin and 0.33
mg/I kinetin;
(iii) fourth medium C, which comprises MS min-
eral salts modified to contain 2,000 mg/I ammo-
nium nitrate, 600 mg/I potassium nitrate, 41.7
mg/I oflSH and 55.9 mg/I Na2EDTA, Sussex's
vitamins, Sussex's amino acids, 2%-3% sucrose,
myoinositol, O.Ql mg/I IAA, 0.1 mg/I kinetin,
0.1 mg/I ABA and 0. 1 mg/I gibberellic acid
(GA3); and
(iv) fourth medium D, which comprises MS min-
eral salts modified to contain 41.7 mg/I ISH and
55.9 mg/I Na2EDTA, vitamins selected from the
group consisting ofNitsch's vitamins modified to
contain 09 mg/I thiamine hydrochloride,
Nitsch's vitamins modified to contain 10.4 mg/I
thiamine hydrochloride and 0.5 mg/I nicotinic
acid and Nitsch's vitamins modified to contain
10.4 mg/I of thiamine hydrochloride, 2%-3%
sucrose, myoinositol, 0.2 mg/I BA and 0.005
mg/I indole-3-butyric acid (IBA)
in the light for about 20-45 days per subculture, to
induce shoot formation; and
(e) subculturing the shoots on one or more solid fifth
media which are selected from the group consist-
ing of:
23
4,837,152
24
medium by culturing in the dark for about 10-21 days
on a solid pre-Conditioning medium which comprises
MS mineral salts modified to contain 41.7 mg/I ISH and
55.9 mg/I Na2EDTA, vitamins selected from the group
consisting of Nitsch's vitamins modified to containing
0.9 mg/I thiamine hydrochloride, Nitsch's vitamins
modified to contain 10.4 mg/I thiamine hydrochloride
and 0.5 mg/I nicotinic acid and Nitsch's vitamins modi-
fied to contain 10.4 mg/I of thiamine hydrochloride,
(i) fifth medium A, which comprises MS mineral
salts modified to contain 41.7 mg/I ISH and 55.9
mg/I Na2EDTA, vitamins selected from the
group consisting ofNitsch's vitamins modified to
contain 0.9 mg/I thiamine hydrochloride, 5
Nitsch's vitamins modified to contain 10.4 mg/I
thiamine hydrochloride and 0.5 mg/I nicotinic
acid and Nitsch's vitamins modified to contain
10.4 mg/I of thiamine hydrochloride, 1%-2%
sucrose and myoinositol;
(ii) fifth medium B;which comprises -MS mineral
salts modified to contain no ammonium nitrate,
300 mg/I NI4H2P04, 2,500 mg/I potassium
nitrate, 41.7 mg/I ISH and 55.9 mg/I Na2EDTA,
vitamins selected from the group consisting of 15
Nitsch's vitamins modified to contain 0.9 mg/I
thiamine hydrochloride, Nitsch's vitamins modi-
fied to contain 10.4 mg/I thiamine hydrochloride
and 0.5 mg/I nicotinic acid and Nitsch's vitamins
modified to contain 10.4 mg/I of thiamine hydro- 20
chloride, 1%-2% sucrose, myoinositol and 0.5
mg/I IAA, and;
10 2%-3% sucrose, myoinositol and 1-2 mg/I 2,4-D.
(iii) fifth medium C, which comprises MS mineral
salts modified to contain 41.7 mg/I ISH and 55.9
mg/I Na2EDTA, vitamins selected from the 25
group consisting ofNitsch's vitamins modified to
contain 0.9 mg/I thiamine hydrochloride,
Nitsch's vitamins modified to contain 10.4 mg/I
thiamine hydrochloride and 0.5 mg/I nicotinic
acid and Nitsch's vitamins modified to contain 30
10.4 mg/I of thiamine hydrochloride, 1%-2%
sucrose, myoinositol ·and a hormone selected
from the group consisting of 0.1-0.5 mg/I IAA
or 0.1-0.5 IBA
in the light for 20-45 days per subculture, to induce 35
root formation whereby plants are obtained.
14. The process of claim 13 wherein the MS mineral
salts of the fourth medium A, fourth medium B, fourth
medium D, fifth medium A and fifth medium C are
further modified to contain one-half the concentration 40
of the macroelements.
· 15. The process of claim 13 wherein the MS mineral
salts of the fourth medium A, fourth medium B, fourth
medium D, fifth medium A and fifth medium C are
further modified to contain one-half the concentration 45
of all of the mineral salts except iron and EDTA.
16. The process of claim 13 wherein the first medium
and second medium further contain an amino acid se-
lected from the group consisting of 800 mg/I L-gluta-
mine or a mixture of 800 mg/I L-glutamine, 350 mg/I 50
L-methionine and 200 mg/I L-asparagine.
17. The process of claim 14 wherein the first medium
and second medium further contain an amino acid se-
lected from the group consisting of 800 mg/I L-gluta-
mine or a mixture of 800 mg/I L-glutamine, 350 mg/I 55
L-methionine and 200 mg/I L-asparagine.
18. The process of claim 15 wherein the first medium
and second medium further contain an amino acid se-
lected from the group consisting of 800 mg/I L-gluta-
mine or a mixture of 800 mg/I L-glutamine, 350 mg/I 60
L-methionine and 200 mg/I L-asparagine.
19. The process of claim 13 wherein the immature
embryo is pre-conditioned prior to culturing on the first
65
20. The process of claim 13 wherein the concentra-
tion of myoinositol in fourth medium C is 1,500 mg/I
and in all other media is 100 mg/I.
21. The process of claim 14 wherein the concentra-
tion of myoinositol in fourth medium C is 1,500 mg/I
and in all other media is 100 mg/I.
22. The process of claim 15 wherein the concentra-
tion of myoinositol in fourth medium C is 1,500 mg/I
and in all other media is 100 mg/I.
23. The process of claim 16 wherein the concentra-
tion of myoinositol in fourth medium C is 1,500 mg/I
and in all other media is 100 mg/I.
24. The process of claim 17 wherein the concentra-
tion of myoinositol in fourth medium C is 1,500 mg/I
and in all other media is 100 mg/I.
25. The process of claim 18 wherein the concentra-
tion of myoinositol in fourth medium C is 1,500 mg/I
and in all other media is 100 mg/I.
26. The process of claim 19 wherein the concentra-
tion of myoinositol in fourth medium C is 1,500 mg/I
and in all other media is 100 mg/I.
27. The process of claim 13 wherein the vitamins in
fourth medium C is Sussex's vitamins and the vitamins
in all other media are Nitsch's vitamins modified to
contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I
nicotinic acid.
28. The process of claim 14 wherein the vitamins in
fourth medium C is Sussex's vitamins and the vitamins
in all other media are Nitsch's vitamins modified to
contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I
nicotinic acid.
29. The process of claim 15 wherein the vitamins in
fourth medium C is Sussex's vitamins and the vitamins
in all other media are Nitsch's vitamins modified to
contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I
nicotinic acid.
30. The process of claim 16 wherein the vitamins in
fourth medium C is Sussex's vitamins and the vitamins
in all other media are Nitsch's vitamins modified to
contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I
nicotinic acid.
31. The process of claim 17 wherein the vitamins in
fourth medium C is Sussex's vitamins and the vitamins
in all other media are Nitsch's vitamins modified to
contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I
nicotinic acid.
32. The process of claim 18 wherein the vitamins in
fourth medium C is Sussex's vitamins and the vitamins
in all other media are Nitsch's vitamins modified to
contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I
nicotinic acid.
• • • • •

More Related Content

What's hot

Does Cryopreservation Stress Impact Genotype Integrity? A Case Study with Ger...
Does Cryopreservation Stress Impact Genotype Integrity? A Case Study with Ger...Does Cryopreservation Stress Impact Genotype Integrity? A Case Study with Ger...
Does Cryopreservation Stress Impact Genotype Integrity? A Case Study with Ger...apaari
 
52.Screeing of industrial production of Cellulase
52.Screeing of industrial production of Cellulase52.Screeing of industrial production of Cellulase
52.Screeing of industrial production of CellulaseAnnadurai B
 
Biolostic transformation of a procaryote, bacillus megaterium
Biolostic transformation of a procaryote, bacillus megateriumBiolostic transformation of a procaryote, bacillus megaterium
Biolostic transformation of a procaryote, bacillus megateriumCAS0609
 
My oral presentation at the Maize Genetics Conference, 2008, Washington DC
My oral presentation at the Maize Genetics Conference, 2008, Washington DCMy oral presentation at the Maize Genetics Conference, 2008, Washington DC
My oral presentation at the Maize Genetics Conference, 2008, Washington DCMihai Miclăuș
 
Screening, identification and isolation of cellulolytic fungi
Screening, identification and isolation of cellulolytic fungiScreening, identification and isolation of cellulolytic fungi
Screening, identification and isolation of cellulolytic fungiDr. sreeremya S
 
Somatic Embryogenesis for the Genetic Improvement of a Triploid Banana (Musa ...
Somatic Embryogenesis for the Genetic Improvement of a Triploid Banana (Musa ...Somatic Embryogenesis for the Genetic Improvement of a Triploid Banana (Musa ...
Somatic Embryogenesis for the Genetic Improvement of a Triploid Banana (Musa ...paperpublications3
 
Characterisation of some Ribes L. accessions from Turkey based on SSRs patterns
Characterisation of some Ribes L. accessions from Turkey based on SSRs patternsCharacterisation of some Ribes L. accessions from Turkey based on SSRs patterns
Characterisation of some Ribes L. accessions from Turkey based on SSRs patternsAgriculture Journal IJOEAR
 
Establishment of an in vitro propagation and transformation system of Balani...
Establishment of an in vitro propagation  and transformation system of Balani...Establishment of an in vitro propagation  and transformation system of Balani...
Establishment of an in vitro propagation and transformation system of Balani...PGS
 
Ecklonia Maxima Extract Effect in Tissue Regeneration of Symbionts at in Vivo...
Ecklonia Maxima Extract Effect in Tissue Regeneration of Symbionts at in Vivo...Ecklonia Maxima Extract Effect in Tissue Regeneration of Symbionts at in Vivo...
Ecklonia Maxima Extract Effect in Tissue Regeneration of Symbionts at in Vivo...IJEAB
 
Alteraton of plant type through mi-RNA expression
Alteraton of plant type through mi-RNA expressionAlteraton of plant type through mi-RNA expression
Alteraton of plant type through mi-RNA expressionNileshJoshi74
 
Intrinsically disordered proteins in abiotic stress management
Intrinsically disordered proteins in abiotic stress managementIntrinsically disordered proteins in abiotic stress management
Intrinsically disordered proteins in abiotic stress managementSukanthBS
 
18. identification of ssr markers for hybridity and seed genetic purity
18. identification of ssr markers for hybridity and seed genetic purity18. identification of ssr markers for hybridity and seed genetic purity
18. identification of ssr markers for hybridity and seed genetic purityVishwanath Koti
 
“Microbiological Analysis Of Soy Milk Produced From Soybean”
“Microbiological Analysis Of Soy Milk Produced From Soybean”“Microbiological Analysis Of Soy Milk Produced From Soybean”
“Microbiological Analysis Of Soy Milk Produced From Soybean”iosrjce
 
Improvement of Crop Production by Means of a Storage Effect
Improvement of Crop Production by Means of a Storage EffectImprovement of Crop Production by Means of a Storage Effect
Improvement of Crop Production by Means of a Storage EffectAgriculture Journal IJOEAR
 
Loss of pollen-specific phospholipase NOT LIKE DAD triggers gynogenesis in maize
Loss of pollen-specific phospholipase NOT LIKE DAD triggers gynogenesis in maizeLoss of pollen-specific phospholipase NOT LIKE DAD triggers gynogenesis in maize
Loss of pollen-specific phospholipase NOT LIKE DAD triggers gynogenesis in maizePGS
 
Presence of genetically modified organism genes in carica papaya, glycine max...
Presence of genetically modified organism genes in carica papaya, glycine max...Presence of genetically modified organism genes in carica papaya, glycine max...
Presence of genetically modified organism genes in carica papaya, glycine max...Carlos Santos Perez
 
Study on the Use of Agricultural Wastes for Cellulase Production by Using Asp...
Study on the Use of Agricultural Wastes for Cellulase Production by Using Asp...Study on the Use of Agricultural Wastes for Cellulase Production by Using Asp...
Study on the Use of Agricultural Wastes for Cellulase Production by Using Asp...IOSR Journals
 
DBT BET JRF Exam Question Paper 2016 and 2017
DBT BET JRF Exam Question Paper 2016 and 2017DBT BET JRF Exam Question Paper 2016 and 2017
DBT BET JRF Exam Question Paper 2016 and 2017Biology Exams 4 U
 

What's hot (20)

Does Cryopreservation Stress Impact Genotype Integrity? A Case Study with Ger...
Does Cryopreservation Stress Impact Genotype Integrity? A Case Study with Ger...Does Cryopreservation Stress Impact Genotype Integrity? A Case Study with Ger...
Does Cryopreservation Stress Impact Genotype Integrity? A Case Study with Ger...
 
52.Screeing of industrial production of Cellulase
52.Screeing of industrial production of Cellulase52.Screeing of industrial production of Cellulase
52.Screeing of industrial production of Cellulase
 
Biolostic transformation of a procaryote, bacillus megaterium
Biolostic transformation of a procaryote, bacillus megateriumBiolostic transformation of a procaryote, bacillus megaterium
Biolostic transformation of a procaryote, bacillus megaterium
 
My oral presentation at the Maize Genetics Conference, 2008, Washington DC
My oral presentation at the Maize Genetics Conference, 2008, Washington DCMy oral presentation at the Maize Genetics Conference, 2008, Washington DC
My oral presentation at the Maize Genetics Conference, 2008, Washington DC
 
Screening, identification and isolation of cellulolytic fungi
Screening, identification and isolation of cellulolytic fungiScreening, identification and isolation of cellulolytic fungi
Screening, identification and isolation of cellulolytic fungi
 
Somatic Embryogenesis for the Genetic Improvement of a Triploid Banana (Musa ...
Somatic Embryogenesis for the Genetic Improvement of a Triploid Banana (Musa ...Somatic Embryogenesis for the Genetic Improvement of a Triploid Banana (Musa ...
Somatic Embryogenesis for the Genetic Improvement of a Triploid Banana (Musa ...
 
2008,pce,gonugunta et al
2008,pce,gonugunta et al2008,pce,gonugunta et al
2008,pce,gonugunta et al
 
Characterisation of some Ribes L. accessions from Turkey based on SSRs patterns
Characterisation of some Ribes L. accessions from Turkey based on SSRs patternsCharacterisation of some Ribes L. accessions from Turkey based on SSRs patterns
Characterisation of some Ribes L. accessions from Turkey based on SSRs patterns
 
Establishment of an in vitro propagation and transformation system of Balani...
Establishment of an in vitro propagation  and transformation system of Balani...Establishment of an in vitro propagation  and transformation system of Balani...
Establishment of an in vitro propagation and transformation system of Balani...
 
Ecklonia Maxima Extract Effect in Tissue Regeneration of Symbionts at in Vivo...
Ecklonia Maxima Extract Effect in Tissue Regeneration of Symbionts at in Vivo...Ecklonia Maxima Extract Effect in Tissue Regeneration of Symbionts at in Vivo...
Ecklonia Maxima Extract Effect in Tissue Regeneration of Symbionts at in Vivo...
 
Alteraton of plant type through mi-RNA expression
Alteraton of plant type through mi-RNA expressionAlteraton of plant type through mi-RNA expression
Alteraton of plant type through mi-RNA expression
 
Intrinsically disordered proteins in abiotic stress management
Intrinsically disordered proteins in abiotic stress managementIntrinsically disordered proteins in abiotic stress management
Intrinsically disordered proteins in abiotic stress management
 
18. identification of ssr markers for hybridity and seed genetic purity
18. identification of ssr markers for hybridity and seed genetic purity18. identification of ssr markers for hybridity and seed genetic purity
18. identification of ssr markers for hybridity and seed genetic purity
 
“Microbiological Analysis Of Soy Milk Produced From Soybean”
“Microbiological Analysis Of Soy Milk Produced From Soybean”“Microbiological Analysis Of Soy Milk Produced From Soybean”
“Microbiological Analysis Of Soy Milk Produced From Soybean”
 
Zeng2014
Zeng2014Zeng2014
Zeng2014
 
Improvement of Crop Production by Means of a Storage Effect
Improvement of Crop Production by Means of a Storage EffectImprovement of Crop Production by Means of a Storage Effect
Improvement of Crop Production by Means of a Storage Effect
 
Loss of pollen-specific phospholipase NOT LIKE DAD triggers gynogenesis in maize
Loss of pollen-specific phospholipase NOT LIKE DAD triggers gynogenesis in maizeLoss of pollen-specific phospholipase NOT LIKE DAD triggers gynogenesis in maize
Loss of pollen-specific phospholipase NOT LIKE DAD triggers gynogenesis in maize
 
Presence of genetically modified organism genes in carica papaya, glycine max...
Presence of genetically modified organism genes in carica papaya, glycine max...Presence of genetically modified organism genes in carica papaya, glycine max...
Presence of genetically modified organism genes in carica papaya, glycine max...
 
Study on the Use of Agricultural Wastes for Cellulase Production by Using Asp...
Study on the Use of Agricultural Wastes for Cellulase Production by Using Asp...Study on the Use of Agricultural Wastes for Cellulase Production by Using Asp...
Study on the Use of Agricultural Wastes for Cellulase Production by Using Asp...
 
DBT BET JRF Exam Question Paper 2016 and 2017
DBT BET JRF Exam Question Paper 2016 and 2017DBT BET JRF Exam Question Paper 2016 and 2017
DBT BET JRF Exam Question Paper 2016 and 2017
 

Viewers also liked

Качество исследуемых лекарственных препаратов для терапии соматическими клетками
Качество исследуемых лекарственных препаратов для терапии соматическими клеткамиКачество исследуемых лекарственных препаратов для терапии соматическими клетками
Качество исследуемых лекарственных препаратов для терапии соматическими клеткамиPHARMADVISOR
 
Visita a la iglesia skate de coruño
Visita a la iglesia skate de coruñoVisita a la iglesia skate de coruño
Visita a la iglesia skate de coruñoisabelri
 
DEB1 still lives DPS
DEB1 still lives DPSDEB1 still lives DPS
DEB1 still lives DPSJihane Miller
 
Клинические исследования на малых популяциях
Клинические исследования на малых популяцияхКлинические исследования на малых популяциях
Клинические исследования на малых популяцияхPHARMADVISOR
 
Valentines Ideas - True Love
Valentines Ideas - True LoveValentines Ideas - True Love
Valentines Ideas - True LoveKen Sapp
 
Обзор модных коллекций. Весна-Лето 2016. Подколзина
Обзор модных коллекций. Весна-Лето 2016. ПодколзинаОбзор модных коллекций. Весна-Лето 2016. Подколзина
Обзор модных коллекций. Весна-Лето 2016. ПодколзинаЖанна Подколзина
 

Viewers also liked (20)

Качество исследуемых лекарственных препаратов для терапии соматическими клетками
Качество исследуемых лекарственных препаратов для терапии соматическими клеткамиКачество исследуемых лекарственных препаратов для терапии соматическими клетками
Качество исследуемых лекарственных препаратов для терапии соматическими клетками
 
Acrostici
Acrostici Acrostici
Acrostici
 
Visita a la iglesia skate de coruño
Visita a la iglesia skate de coruñoVisita a la iglesia skate de coruño
Visita a la iglesia skate de coruño
 
DEB1 still lives DPS
DEB1 still lives DPSDEB1 still lives DPS
DEB1 still lives DPS
 
SELVAM.CV
SELVAM.CVSELVAM.CV
SELVAM.CV
 
Decoracao com-moda-mkp
Decoracao com-moda-mkpDecoracao com-moda-mkp
Decoracao com-moda-mkp
 
Клинические исследования на малых популяциях
Клинические исследования на малых популяцияхКлинические исследования на малых популяциях
Клинические исследования на малых популяциях
 
Seo company in dwarka delhi
Seo company in dwarka delhiSeo company in dwarka delhi
Seo company in dwarka delhi
 
Estrategia de procesos
Estrategia de procesosEstrategia de procesos
Estrategia de procesos
 
Valentines Ideas - True Love
Valentines Ideas - True LoveValentines Ideas - True Love
Valentines Ideas - True Love
 
MonCV2
MonCV2MonCV2
MonCV2
 
Inducción proceso de comunicaciones
Inducción proceso de comunicaciones Inducción proceso de comunicaciones
Inducción proceso de comunicaciones
 
ShortUrlApp-iis-like
ShortUrlApp-iis-likeShortUrlApp-iis-like
ShortUrlApp-iis-like
 
Poesia
Poesia Poesia
Poesia
 
Gli stati della materia
Gli stati della materiaGli stati della materia
Gli stati della materia
 
Foreign Assistance Newsletter - June/July 2016 Edition
Foreign Assistance Newsletter - June/July 2016 EditionForeign Assistance Newsletter - June/July 2016 Edition
Foreign Assistance Newsletter - June/July 2016 Edition
 
A grande tribulação
A grande tribulaçãoA grande tribulação
A grande tribulação
 
Inducciòn salud y seguridad en el trabajo
Inducciòn salud y seguridad en el trabajoInducciòn salud y seguridad en el trabajo
Inducciòn salud y seguridad en el trabajo
 
Proyecto holmquist
Proyecto holmquistProyecto holmquist
Proyecto holmquist
 
Обзор модных коллекций. Весна-Лето 2016. Подколзина
Обзор модных коллекций. Весна-Лето 2016. ПодколзинаОбзор модных коллекций. Весна-Лето 2016. Подколзина
Обзор модных коллекций. Весна-Лето 2016. Подколзина
 

Similar to Patent_written by Dr. John Hemphill

nduced Mutation by Colchicine Treatment of Somatic Embryos in ‘Namwa’ Banana ...
nduced Mutation by Colchicine Treatment of Somatic Embryos in ‘Namwa’ Banana ...nduced Mutation by Colchicine Treatment of Somatic Embryos in ‘Namwa’ Banana ...
nduced Mutation by Colchicine Treatment of Somatic Embryos in ‘Namwa’ Banana ...drboon
 
Anther culture in vegetable crops
Anther culture in vegetable cropsAnther culture in vegetable crops
Anther culture in vegetable cropsShanwaz Ahmad
 
Case study report on sugarcane
Case study report on sugarcaneCase study report on sugarcane
Case study report on sugarcaneArun Nagarajan
 
RECENT STUDIES ON SYNTHETIC SEED PRODUCTION IN HORTICULTURAL CROPS.pptx
 RECENT STUDIES ON SYNTHETIC SEED PRODUCTION  IN HORTICULTURAL CROPS.pptx RECENT STUDIES ON SYNTHETIC SEED PRODUCTION  IN HORTICULTURAL CROPS.pptx
RECENT STUDIES ON SYNTHETIC SEED PRODUCTION IN HORTICULTURAL CROPS.pptxAKHILRDONGA
 
Plant Cell Immobilization for Secondary Metabolite Production with Examples.pptx
Plant Cell Immobilization for Secondary Metabolite Production with Examples.pptxPlant Cell Immobilization for Secondary Metabolite Production with Examples.pptx
Plant Cell Immobilization for Secondary Metabolite Production with Examples.pptxChhavi Singh
 
Embryogenesis 27 mar 15
Embryogenesis 27 mar 15Embryogenesis 27 mar 15
Embryogenesis 27 mar 15avinash sharma
 
Plant Tissue Culture stage iii rooting
Plant Tissue Culture stage iii rootingPlant Tissue Culture stage iii rooting
Plant Tissue Culture stage iii rootingKAUSHAL SAHU
 
In vitro regeneration of multiple shoots from encapsulated somatic embryos of...
In vitro regeneration of multiple shoots from encapsulated somatic embryos of...In vitro regeneration of multiple shoots from encapsulated somatic embryos of...
In vitro regeneration of multiple shoots from encapsulated somatic embryos of...IOSR Journals
 
58833070-17a4-4647-ada7-8edbb27bfb1a.pdf
58833070-17a4-4647-ada7-8edbb27bfb1a.pdf58833070-17a4-4647-ada7-8edbb27bfb1a.pdf
58833070-17a4-4647-ada7-8edbb27bfb1a.pdfJane756411
 
CRYOPRESERVATION.pptx
CRYOPRESERVATION.pptxCRYOPRESERVATION.pptx
CRYOPRESERVATION.pptxsatish rana
 
CRYOPRESERVATION.pptx
CRYOPRESERVATION.pptxCRYOPRESERVATION.pptx
CRYOPRESERVATION.pptxsatish rana
 
Bt maize insect resistance to lepidopteran pest
Bt maize insect resistance to lepidopteran pestBt maize insect resistance to lepidopteran pest
Bt maize insect resistance to lepidopteran pestPavan R
 
production of double haploid in crops
production of double haploid in cropsproduction of double haploid in crops
production of double haploid in cropssumitparmar27
 
Artificial Seed - Definition, Types & Production
Artificial Seed - Definition, Types & Production Artificial Seed - Definition, Types & Production
Artificial Seed - Definition, Types & Production ANUGYA JAISWAL
 
Morphogenesis, organogenesis, embryogenesis & other techniques
Morphogenesis, organogenesis, embryogenesis & other techniquesMorphogenesis, organogenesis, embryogenesis & other techniques
Morphogenesis, organogenesis, embryogenesis & other techniquesHORTIPEDIA INDIA
 
Plant tissue culture & animal tissue culture practical experiments
Plant tissue culture & animal tissue culture practical experimentsPlant tissue culture & animal tissue culture practical experiments
Plant tissue culture & animal tissue culture practical experimentsBangaluru
 
Banana plantlet production through tissueculture
Banana plantlet production through tissuecultureBanana plantlet production through tissueculture
Banana plantlet production through tissuecultureAbed Hawas
 

Similar to Patent_written by Dr. John Hemphill (20)

1Pérez núñez2006Coconut.pdf
1Pérez núñez2006Coconut.pdf1Pérez núñez2006Coconut.pdf
1Pérez núñez2006Coconut.pdf
 
nduced Mutation by Colchicine Treatment of Somatic Embryos in ‘Namwa’ Banana ...
nduced Mutation by Colchicine Treatment of Somatic Embryos in ‘Namwa’ Banana ...nduced Mutation by Colchicine Treatment of Somatic Embryos in ‘Namwa’ Banana ...
nduced Mutation by Colchicine Treatment of Somatic Embryos in ‘Namwa’ Banana ...
 
Anther culture in vegetable crops
Anther culture in vegetable cropsAnther culture in vegetable crops
Anther culture in vegetable crops
 
Case study report on sugarcane
Case study report on sugarcaneCase study report on sugarcane
Case study report on sugarcane
 
RECENT STUDIES ON SYNTHETIC SEED PRODUCTION IN HORTICULTURAL CROPS.pptx
 RECENT STUDIES ON SYNTHETIC SEED PRODUCTION  IN HORTICULTURAL CROPS.pptx RECENT STUDIES ON SYNTHETIC SEED PRODUCTION  IN HORTICULTURAL CROPS.pptx
RECENT STUDIES ON SYNTHETIC SEED PRODUCTION IN HORTICULTURAL CROPS.pptx
 
Plant Cell Immobilization for Secondary Metabolite Production with Examples.pptx
Plant Cell Immobilization for Secondary Metabolite Production with Examples.pptxPlant Cell Immobilization for Secondary Metabolite Production with Examples.pptx
Plant Cell Immobilization for Secondary Metabolite Production with Examples.pptx
 
Embryogenesis 27 mar 15
Embryogenesis 27 mar 15Embryogenesis 27 mar 15
Embryogenesis 27 mar 15
 
Synthetic seed production By- Parvati Pujar
Synthetic seed production By- Parvati PujarSynthetic seed production By- Parvati Pujar
Synthetic seed production By- Parvati Pujar
 
Anther culture & its importance in vegetable crops
Anther culture & its importance in vegetable cropsAnther culture & its importance in vegetable crops
Anther culture & its importance in vegetable crops
 
Plant Tissue Culture stage iii rooting
Plant Tissue Culture stage iii rootingPlant Tissue Culture stage iii rooting
Plant Tissue Culture stage iii rooting
 
In vitro regeneration of multiple shoots from encapsulated somatic embryos of...
In vitro regeneration of multiple shoots from encapsulated somatic embryos of...In vitro regeneration of multiple shoots from encapsulated somatic embryos of...
In vitro regeneration of multiple shoots from encapsulated somatic embryos of...
 
58833070-17a4-4647-ada7-8edbb27bfb1a.pdf
58833070-17a4-4647-ada7-8edbb27bfb1a.pdf58833070-17a4-4647-ada7-8edbb27bfb1a.pdf
58833070-17a4-4647-ada7-8edbb27bfb1a.pdf
 
CRYOPRESERVATION.pptx
CRYOPRESERVATION.pptxCRYOPRESERVATION.pptx
CRYOPRESERVATION.pptx
 
CRYOPRESERVATION.pptx
CRYOPRESERVATION.pptxCRYOPRESERVATION.pptx
CRYOPRESERVATION.pptx
 
Bt maize insect resistance to lepidopteran pest
Bt maize insect resistance to lepidopteran pestBt maize insect resistance to lepidopteran pest
Bt maize insect resistance to lepidopteran pest
 
production of double haploid in crops
production of double haploid in cropsproduction of double haploid in crops
production of double haploid in crops
 
Artificial Seed - Definition, Types & Production
Artificial Seed - Definition, Types & Production Artificial Seed - Definition, Types & Production
Artificial Seed - Definition, Types & Production
 
Morphogenesis, organogenesis, embryogenesis & other techniques
Morphogenesis, organogenesis, embryogenesis & other techniquesMorphogenesis, organogenesis, embryogenesis & other techniques
Morphogenesis, organogenesis, embryogenesis & other techniques
 
Plant tissue culture & animal tissue culture practical experiments
Plant tissue culture & animal tissue culture practical experimentsPlant tissue culture & animal tissue culture practical experiments
Plant tissue culture & animal tissue culture practical experiments
 
Banana plantlet production through tissueculture
Banana plantlet production through tissuecultureBanana plantlet production through tissueculture
Banana plantlet production through tissueculture
 

Patent_written by Dr. John Hemphill

  • 1. J United States Patent [191 · Hemphill et al. [54] PROCESS FOR REGENERATING SOYBEANS [75] Inventors: John K. Hemphill, Cupertino; Claire A. Warshaw, Palo Alto, both of Calif. [73] Assignee: Sungene Technologies Corporation, Palo Alto, Calif. [ • ] Notice: The portion of the term ofthis patent subsequent to Aug. 4, 2004 has been disclaimed. [21] Appl. No.: 890,302 [22] Filed: Jul. 29' 1986 [51] Int.Cl.4 ............................................... C12N5/00 [52] U.S. Cl•............................ 435/240.49; 435/240.5; 435/240.54 [58] Field of Search ............ 435/240.5, 240.49, 240.54 [56] References Cited U.S. PATENT DOCUMENTS 4,003,156 1/1977 Sibi et al. . 4,684,612 8/1987 Hemphill et al. ................ 435/240.5 OTHER PUBLICATIONS Hu et al., 1983, p. 213, In: Handbook of Plant Cell Cul- ture, vol. 1, Evans et al., eds., Macmillan: New York. Stuart et al., 1984, Plant Sci. Lett. 34:165-174. Tilton et al., 1984, J. Plant Physiol. 115:191-200. [11] Patent Number: [45] Date of Patent: 4,837,152 *Jun. 6, 1989 Phillips et al., Plant Cell Tissue Organ Culture 1, 123 (1981). Widhalm et al., Plant Cell Reports 2, 19 (1983). Gamborg et al., Plant Cell Repons 2, 209 (1983a). Gamborg et al., Plant Cell Repons 2, 213 (1983b). Christianson et al., Science 222, 632 (1983). Ranch et al., In Vitro Cell Develop. Biol. 21, 653 (1985). ··Barwale et al., Planta 167, 473 (1986). Kerns et al., Plant Cell Repons 5, 140 (1986). Lazzeri et al., Plant Malec. Biol Rptr. 3, 160 (1985). Li et al., Plant Cell Reports 4, 344 (1985). Grant, Plant Cell, Tissue and Organ Culture 3, 169 (1984). Wright et al., Plant Cell Repons 5, 150 (1986). Cheng et al., Plant Science Letters 19, 91 (1980). Saka et al., Plant Science Letters 19, 193 (1980). Kameya et al., Plant Science Letters 21, 289 (1981). Ghazi, T. D. et al., Plant Cell Reports 5, 452 (1986). Primary Examiner-Charles F. Warren Assistant Examiner-David T. Fox Attorney, Agent, or Firm-Robbins & Laramie [57] ABSTRACT The present invention relates to the regeneration of soybeans. The process comprises the steps of inducing callus and embryoid formation from tissue of a soybean plant, maturing the embryoids, germinating the ernbry- oids, and forming roots on the germinated embryoids. 32 Claims, No Drawings
  • 2. ~ ,. :-~ :--·:. ... • .. ::·... .. ·• .. . 4,837,152 1 PROCESS FOR REGENERATING SOYBEANS 2 containing 0.5 mg/I a-naphthalene acetic acid (NAA) followed in series by MS basal medium containing 0.5 mg/l of indoleacetic acid (IAA) and 5 mg/l benzylade- nine (BA), and finally MS basal medium containing 0.5CROSS REFERENCE TO RELATED APPLICATION 5 mg/l BA. The present invention is related to copending applica- tion Ser. No. 635,222, filed July 27, 1984, U.S. Pat. No. 4,684,612, incorporated by reference herein. Gamberg et al., in Plant Cell Reports 2, 209 (l983a), disclose somatic embryogenesis from cell suspension culture in several Glycine species including three culti- vars (out of seven tested) of Glycine max. The embryoid BACKGROUND OF THE INVENTION 10 induction medium utilized consisted of the major salts 1. Field of the Invention · · The present invention relates to an improved process for regenerating soybeans (Glycine max (L.) Merrill). More particularly, the invention relates to the use of tissue and cell culture for the regeneration of soybean 15 plantlets for many soybean varieties. The invention also relates to the media used in this process. · of SL; the micronutrients -and vitamins of BS, 10 mg/I casamino acids, 15 µM adenine sulfate, 0.2 µM picloram and 0.025-0.25 µMAMO 1618. It was discovered that picloram was necessary for embryo induction and that it could be replaced by 0.5 to 2.0 µM 2,4-D. No embry- oids were induced when the auxins NAA, lAA or in- 2. Description of the Prior Art Plant regeneration from cells in culture is essential for the application ofsomatic hybridization, for the produc- 20 tion of new varieties through somoclonal variation and for the use of genetic engineering in producing new varieties. Although plants can be regenerated from single cells of a large number ofcrop species, the efforts with soybean have generally been unsuccessful. 25 In recent years, plant cell culture successes have had a considerable influence on the understanding of the respective roles of cell and organism in control of plant growth and development. Isolated plant cells have been shown to be amenable to in vitro culture and complete 30 plants could be regenerated from cultures derived from somatic cells, either directly via somatic embryogenesis or indirectly via organogenesis. Generally the regenera- tion pathway of choice is determined empirically by the manipulation of extrinsic factors, especially growth 35 regulators. Early investigations of certain plant species have suggested that exogenous auxin concentration is the major factor controlling somatic embryogenesis, such that its reduction leads to the initiation of embry- oid formation. In other species, exposure to a definite 40 balance of auxin and cytokinin leads to the formation of organogenesis (shoots, then roots). Phillips et al., in Plant Cell Tissue Organ Culture. 1, 123 (1981), described the somatic embryogenesis of soybean in cell suspension or on agar. They utilized 45 hypocotyl or epicotyl tissue for callus initiation on L2 medium. Cell suspension cultures were initiated from callus tissue in S2 medium. The cell suspension culture could be used to produce globular and heart-shaped embryos or additional callus which could form shoot 50 buds. The formation of somatic embryos or shoot buds was reproducible using basal S2 or L2 media supple- mented with 100 mg/l casein hydrolysate, 2.25 µM 2,4-dichlorophenoxyacetic acid (2,4-D), 0.1 µM abscisic acid (ABA), 0.1 µM 2-isopropyl-4-dimethylaminoS- 55 methylphenyl-1-piperidine carboxymethyl chioride (AMO 1618) and either 15 µM adenine or 0.46 µM kinetin. Although somatic embryos or shoot buds were formed, on plants were obtained for any varieties of Glycine max. 60 Wildholm et al., in Plant Cell Reports 2, 19 (1983), describe the formation of shoots from Glycine canescens callus obtained from hypocotyls or cotyledons. Root formation did not occur, so no plantlets were obtained. The method did not produce shoots when Glycine max 65 (soybean) was the source of the tissue. The formation of shoots from Glycine canescens tissue culture was achieved through callus induction on BS basal medium dole-3-butyric acid (IBA) were utilized in place of the auxins picloram or 2,4-D. After embryoids were in- duced, they were transferred to embryo growth me- dium which consisted of SL medium containing various combinations of cytokinins (zeatin or BA), auxins (pi- cloram) and gibberellic acid (GA3). Embryoids which were formed went to a heart-shaped structure, but failed to develop beyond this stage on the induction medium. Transfer to the growth medium did result in the formation of roots, but shoots were not formed. The use of MS medium or addition of abscisic acid, coconut milk or change in osmolarity did not result in further development. Gamberg et al., in Plant Cell Reports 2, 213 (1983b), describe the preparation of protoplasts from cell cul- tures of Glycine tabacina and Glycine soja and from leaf tissue from the soybean Glycine max cultivar (cv.) Wil- liams 82. The protoplasts formed cells which could be induced to form heart-shaped embryos by the proce- dure of Gamberg et al (1983). As in the latter reference, no plantlets were formed from the procedure. Christianson et al, in Science 222, 632 (1983a), disclose the regeneration of a plantlet from cell suspension cul- ture of the soybean Glycine max (L.) Merrill cv. Mitch- ell. This appears to have been the result of a random even and appears to have resulted from a piece of clonal tissue. Immature embryos were aseptically removed from 2.5-3.0 cm pods, and embryo axes were cut into 1-2 mm pieces. These pieces were placed on a solid medium to induce callus formation. This medium con- sisted of MS salts, 0.5 mg/I nicotinic acid, 0.5 mg/I pyridozine, 100 mg/l thiamine, 100 mg/I inositol, 2% sucrose and 5 mg/l 2,4-D. The hard, non-friable tissue was selected for transfer to new medium and resulted in a tissue line that gave rise to hard, green, glossy, abnor- mal embryos. When the callus tissue was transferred from the induction medium to a N-amended medium and then transferred back to the induction medium, one exceptional piece of tissue was obtained which was covered with small embryoids. The N-amended me- dium consisted of the induction medium in which the two nitrogen salts of the MS salts were replaced with 20 mM ammonium citrate. Transfer of the embryoids to a medium containing 0.005 mg/I IBA and 0.2 mg/I BA gave rise to shoot formation. Transfer of the shoots to a basal medium containing 0.1 mg/1 of !AA resulted in root formation to produce plantlets. This procedure does not appear to be generally applicable for regener- ating soybean cultivars, but instead appears to have been a random event which may not be reproducible. Support for this analysis lies in Christianson et al.'s
  • 3. 3 4,837,152 4 source of the embryogenic tissue. Christianson et aL state that "one exceptional piece of tissue" with embry- oids was obtained. Since only one was obtained out of many initiated, it implies that this regeneration ·was a random even and could have been clonal in nature. 5 (d) rooting the germinated embryoids by subcultur- ing on a fourth medium comprising mineral salts, vita- mins, sucrose and optionally a hormone selected from the group consisting of IAA and IBA. In a second embodiment, the process comprises the steps of: -Copending application Ser. No. 356,222 discloses a method for regenerating several cultivars of soybean (Glycine max). In the process described in that applica- tion, an immature embryo is cultured in the light on a first medium which contains either 2,4-D, a mixture of 2,4-D and IAA, or a mixture of2,4-D, IAA and ABA as the hormone to induce callus formation and embryoid formation from the callus. The embryoids are matured (a) inducing pre-callus formation from tissue of a soybean plant by culturing on a first medium compris- ing mineral salts, vitamins, 2,4-D and optionally amino 10 acids; by culturing them on a second medium which is se- lected from a group of five media. The mature embry- oids are then cultured on a third medium to induce shoot formation. The hormone utilized in the third me- dium may be a mixture of IBA and BA, a mixture of IAA and adenine sulfate, a mixture of IBA, BA and GA3, or a mixture of IAA, BA and GA3. Shoots are transferred to a fourth medium which is either hor- mone-free or contains the hormone IAA or IBA to induce the formation of roots. ·· · (b) completing the formation of callus, and forming embryoids and partially maturing the embryoids by subculturing on a second medium comprising mineral salts, vitamins, sucrose, a mixture of 2,4-D, ABA and 15 IAA and optionally amino acids; (c) further maturing the embryoids by subculturing on a liquid third medium comprising mineral salts, vita- mins, sucrose, amino acids and a mixture of 2,4-D and ABA; 20 (d) germinating the embryoids by subculturing on a fourth medium comprising mineral salts, vitamins, su- crose and a hormone selected from the group consisting of a mixture of NAA, BA, t-zeatin and kinetin, a mix- ture of IAA, kinetin, ABA and GA3 and a mixture of BA and IBA; and (e) rooting the germinated embryoids by subculturing on a fifth medium comprising mineral salts, vitamins, sucrose and optionally a hormone selected from the group consisting of IBA and IAA. Ranch, J.P., et al., In Vitro Cell Develop. Boil 21, 653 (1985) discloses a method for regenerating several culti- 25 vars of soybean. In this process, callus tissue is initiated and somatic embryos formed by culturing immature embryos in the light (50 lux) on a first medium. which contains 2,4-D. The somatic embryos are matured in the dark by culturing on a medium which contains IBA or 30 The soybean donor tissue may also be cultured on a preconditioning medium prior to culturing on the first medium in the second embodiment. The pre-condition- ing medium comprises mineral salts, vitamins, sucrose and 2,4-D. a mixture of IBA and ABA as the hormone. The matu- ration medium is either liquid or solid. The embryos are germinated by culturing in the light (100 lux) on a me- dium containing a mixture of IBA and GA3 as the hor- mone. The young plants are transferred to medium containing IBA for root development and cultured in the light (1500 lux). 35 The source of the tissue is preferably immature em- Soybean plants and seeds are produced by this pro- cess. The resulting soybean plants may differ from the starting plant material as a result of somoclonal varia- 40 tion. The pathway is also useful in that it will enable the use of various selection processes to provide further variation. Plants which are produced can be used in conventional breeding programs. bryos from cultivars of Glycine max (L.) Merrill. Suit- able cultivars include Williams 82, Corsoy 79, Forrest, Mitchell 450, Beeson 80, Miami, Century 84, Evans, Gnome, and Northrup King variety 5-18-84-8032-23. DETAILED DESCRIPTION OF THE INVENTION The present invention is directed to an improved process for regenerating soybeans (Glycine max) SUMMARY OF THE INVENTION 45 through the use of cell or tissue culture. In this process, regenerated soybean plantlets are obtained which can be placed in soil and grown to maturation. The present invention is also directed to soybean plants obtained by The process of the present invention comprises the steps of inducing callus and embryoid formation from tissue of a soybean plant, maturing the embryoids, ger- minating the embryoids, and forming roots on the ger- 50 minated embryoids. More specifically, in one embodiment, the present process comprises the steps of: (a) inducing callus and embryoid formation from tissue of a soybean plant by culturing on a first medium 55 comprising mineral salts, vitamins, sucrose, 2,4-D, and optionally ABA and/or amino acids; (b) maturing the embryoids by subculturing on a second medium comprising mineral salts, vitamins, su- crose and a hormone selected from the group consisting 60 of a mixture of IAA and t-zeatin and a mixture of IAA, t-zeatin, ABA and picloram; · (c) germinating the embryoids by subculturing the embryoids on a third medium comprising mineral salts, vitamins, sucrose, a hormone selected from the group 65 consisting of a mixture of IAA, kinetin, ABA and GA3 and a mixture of BA and IBA and optionally amino acids; and this process and seeds obtained from these plants. In general, the process comprises (a) inducing callus and embryoid formation from donor tissue of a soybean plant, (b) maturing the embryoids, (c) germinating the mature embryoids, and (d) forming roots on the germi- nated embryoids which results in the formation of a plant or plantlet. Optionally, in one embodiment, the soybean donor tissue can be first pre-conditioned before being placed into this process. Each of the media uti- lized in this process contain mineral salts, vitamins and sucrose. In addition, each medium contains a different scheme of hormones to accomplish the desired result, i.e., plant regeneration. The plant donor tissue which is preferred for use in the initiation of callus and embryoid formation is the immature embryo. The immature embryos are isolated from pods which are periodically harvested from the soybean plant. Pods are usually harvested when they reach the size of 1.5-2.5 cm in length. The pods are surface-sterilized and the embryos are removed asepti-
  • 4. 5 4,837,152 6 cally. The embryos are 0.5-7 mm in length. It is pre- ferred to use embryos that are 1-4 mm in length. If the embryos are smaller than l mm, they must be matured before being plated onto the first medium. Embryos can be matured as described in copending application Ser. 5 No. 635,222. At least two embodiments can be utilized to regener- ate soybeans in accordance with the present invention. The first embodiment is slower than the second, espe- cially through the steps of callus induction, embryoid IO formation and embryoid maturation. Each embodiment will be described separately. In the first step of the first embodiment, the immature embryo is cultured to induce callus and embryoid for- mation. This is accomplished by culturing the immature 15 embryos on a first medium A. The first medium A comprises mineral salts, vitamins and sucrose. The mineral salts comprise macroelements and microelements. The macroelements used in the first medium may be the following compounds: magnesium 20 sulfate, calcium chloride, monopotassium phosphate, potassium nitrate and ammonium nitrate. The microele- ments contained in the first medium A are: boric acid, manganese sulfate, zinc sulfate, sodium molybdate (VI), copper (II) sulfate, cobalt chloride, potassium, iodide, 25 iron (II) sulfate and disodiuni EDTA. The preferred amounts of the macroelements and microelements used to prepare one liter of the first medium A are as follows: 370 mg magnesium sulfate heptahydrate, 440 mg calcium chloride dihydrate, 170 30 mg monopotassium phosphate, 1900 mg potassium ni- trate, 1650 mg ammonium nitrate, 6.2 mg boric acid, 16.9 mg manganese sulfate monohydrate, 8.6 mg zinc sulfate heptahydrate, 0.25 mg sodium molybdate (VI) dihydrate, 0.025 mg copper (II) sulfate pentahydrate, 35 0.025 mg cobalt chloride hexahydrate, 0.83 mg potas- sium iodide, 41.7 mg iron (II) sulfate heptahydrate, and 55.9 mg disodium EDTA. This combination of mineral salts is known in the art as the MS mineral salts, which has been modified so that the medium contains more 40 iron and EDTA, one and one-half times more than the standard MS mineral salts. The first medium A also contains vitamins. The vita- mins used include nicotinic acid, glycine, pyridoxine, thiamine, folic acid and biotin. These vitamins are 45 known in the art as Nitsch's vitamins. The Nitsch's vitamins have been modified so that they contain more thiamine, and optionally less nicotinic acid. In addition to these vitamins, the first medium also contains myo- inositol. The amount of myoinositol utilized may be 100 50 mg/I, 1,500 mg/l or 1,600 mg/l. The preferred amounts of vitamins used to prepare one liter of the first medium A are as follows: 5 mg nicotinic acid, 2 mg glycine, 0.5 mg pyridoxine hydro- chloride, 0.9 mg thiamine hydrochloride, 0.5 mg folic 55 acid and 0.05 mg biotin. This vitamin mixture will be referred to herein as modified Nitsch's vitamins A, and is preferred in the first medium. It is also possible to utilize modified Nitsch's vitamins B. This vitamin mix- ture is identical except that 10.4 mg/I thiamine hydro- 60 chloride and 0.5 mg/l nicotinic acid are used. A third vitamin mixture may also be used, which will be re- ferred to herein as modified Nitsch's vitamins C. This vitamin mixture is identical to modified Nitsch's vita- mins A, except that 10.4 mg/I thiamine hydrochloride is 65 used. The first medium A contains 2%-3% sucrose, prefer- ably 2%, and a gelling substance such as agar or Gelrite (trademark, Kelco Commercial Development). It is preferred to use Gelrite at a concentration of0.2%. The medium has a pH of 5.5-6.0 with a preferred pH of 5.8. In addition to the above components, the first me- dium A also contains 2,4-D as the hormone. 2,4-D is generally present in the first medium A at a concentra- tion of about 5 mg/I to about 10 mg/I. It is preferred to use 5 mg/12,4-D in the first medium A. Optionally, first medium A also contains ABA at a concentration of about 0.0264 mg/I. The first medium may also option- ally contain amino acids selected from the group con- sisting of L-glutamine at a concentration of 2.19 g/1 and a mixture of 800 mg/I L-glutamine, 350 mg/I L-methio- nine and 200 mg/I L-asparagine. This latter combina- tion will be referred to herein as amino acids. A. The first medium A is sterilized by autoclaving all of the components except the vitamins, amino acids, ABA and 2,4-D which are sterilized by microporous membrane filtration. It is preferred to culture to immature embryo on the first medium for about 25 to about 35 days before trans- ferring to the second medium. Culturing on the first medium is conducted in the light, such as a Grow-Lux fluorescent light or a cool white fluorescent light, with a photoperiod of 16 hours, at a temperature of 25°-29° c. After culturing the immature embryo on the first medium, the callus with embryoids is subcultured on a second medium to mature the embryoid. The callus with the embryoids is subcultured on the second me- dium in the light for 20-45 days, preferably for about 25-35 days per subculture, to mature the embryoids. It may be necessary to transfer the maturing embryoids to fresh medium during this time period in order to obtain complete maturation. The maturing embryoids are transferred based on their morphological appearance, i.e., their similarity to natural zygotic embryos. Any second medium may be utilized for the transfer. The second medium may be selected from a group consisting of three different media. Each second me- dium contains 2% to 3%, preferably 2%, sucrose and a gelling substance, preferably Gelrite. In addition to these components, the second medium may also contain 1,000-4,000 mg/I mannitol. The pH is 5.5-6.0, prefera- bly 5.8. Each medium is sterilized by autoclaving except the vitamins and hormones, which are filter-sterilized. Second medium A comprises mineral salts, vitamins, casein hydrolysate and a hormone. The mineral salts are the same as in the first medium, except that 4.524 g of ammonium citrate and 1.010 g of KN03 are utilized in place of 1.65 g of ammonium nitrate and 1.9 g of KN03. This composition will be referred to as mineral salts A. The vitamins are the same as in the first medium, prefer- ably modified Nitsch's vitamins A. 100 mg/I of myoino- sitol is preferably used. Preferably 100 mg/I of casein hydrolysate is utilized, as is 0.4% Gelrite. The hormone which is utilized is a mixture of IAA, t-zeatin, ABA and picloram. It is preferred to use about 1.0 mg/I IAA, about 1.0 mg/I t-zeatin, about 0.0264 mg/I ABA, and about 0.0096 mg/I picloram. Second medium B comprises the same mineral salts and vitamins as in the first medium. It is preferred to use modified Nitsch's vitamins A. 100 mg/I of myoinositol is preferably used. The hormone which is utilized in second medium B is a mixture of IAA and t-zeatin, preferably at a concentration of about 1 mg/I IAA and 0.5 mg/I t-zeatin.
  • 5. 7 4,837,152 8 Second medium C comprises mineral salts, vitamins, casein hydrolysate and a hormone. The mineral salts are the same as in the first medium, except that 4.524 g/I of ammonium citrate is used in place of ammonium nitrate and KN03. This composition of mineral salts will be 5 referred to as mineral salts B. Myoinositol is preferably present at 100 mg/I, and 100 mg/I of casein hydrolysate is used. 0.4 mg/I Gelrite is used in this medium. The vitamins are the same as in the first medium, preferably modified Nitsch's vitamins A. The hormone which is 10 utilized is the same as in second medium A. In this embodiment, the most preferred second me- dium is second medium C, with second medium B being the next preferred medium. After maturing the embryoids, the third step is to 15 germinate the embryoids by transferring and subcultur- ing them on a germinating medium, hereinafter referred to as the third medium. The embryoids are subcultured on the third medium in the light for 20-45 days, prefera- bly for about 25-35 days per subculture. It may be nee- 20 essary to transfer the material to fresh medium during this time period. Iftransfers are made, they may be done after 20-45 days, preferably after 30 days. Transferring is usually done if the shoots have not elongated prop- erly. That is, ifthe shoots do not have two sets ofleaves, 25 they are transferred to fresh third medium or onto a modified third medium containing one-half the concen- tration of the macroelements other than iron or one-half the concentration of all of the mineral salts except for iron, with the other components being the same, before 30 they are placed on the fourth medium. It is preferred to use one or more subcultures on modified third medium B, as described further below, if additional transfers are necessary. The third medium which can be utilized to germinate 35 the embryoids may be selected from a group consisting of two different media, hereinafter referred to as third medium A or B. Each third medium contains 2%-3%, preferably 2%, sucrose and a gelling substance, prefera- bly 0.2% Gelrite. The pH is 5.5-6.0, preferably 5.8. 40 Each medium is sterilized by autoclaving, except that the vitamins, hormones and amino acids are sterilized by membrane filtration. Third medium A comprises mineral salts, vitamins, amino acids and a hormone. The mineral salts are the 45 same as used in the first medium, except that 2 g of Nf4N03 and 600 mg of KN03 are used. This combina- tion of mineral salts will be referred to as mineral salts C. The vitamins which are used include thiamine hy- drochloride and pyridoxine hydrochloride. THe vita- 50 mins are known in the art as Sussex's vitamins. Sussex's vitamins are present at 15 mg/I thiamine hydrochloride and l.5 mg/I pyridoxine hydrochloride. Myoinositol is preferably present at 1,500 mg/I concentration. The amino acids which are used include L-glutamine, L- 55 serine and L-asparagine. The mixture of these·vitamins is known in the art as Sussex's amino acids. Preferred amounts of these amino acids are 500 mg/I L-glutamine, 100 mg/I L-serine and 100 mg/I L-asparagine. The hormone which is utilized is a mixture of IAA, kinetin, 60 ABA and GA3. It is preferred to use about 0.01 mg/I IAA, 0.1 mg/I kinetin, 0.1 mg/I ABA and 0.1 mg/I GA3. Third medium B comprises mineral salts, vitamins and a hormone. The mineral salts and vitamins are the 65 same as used in the first medium. Preferably, modified Nitsch's vitamins A is utilized, as is 100 mg/I myoinosi- tol. The hormone which may be utilized is a mixture of BA and IBA, preferably at a concentration of 0.2 mg/I, BA, and 0.005 mg/I IBA. In addition, a mineral salt composition which has the same concentration of mi- croelements and iron as the first medium, but only one- half the concentration of the macroelements, can be used in this medium. Such a combination will be re- ferred to herein as mineral salts D. Alternatively, a mineral salt composition which has one-half the con- centration of all of the mineral salts, except iron, can be used. Such a combination will be referred to herein as mineral salts E. These compositions with lower mineral salt concentrations will be referred to herein as modi- fied third medium B. After germinating the embryoids, the fourth step is to root the germinated embryoids by transferring to a root-forming medium, hereinafter referred to as the fourth medium. The shoots are subcultured on the fourth medium in the light for 20-60 days, preferably for about 30 days. Due to slow root development, it may be necessary to transfer the material to fresh me- dium during this time period. The transfer can be to fresh fourth medium or to a modified fourth medium A or C in which all the macroelements, except iron, are present at one-half the concentration in the original fourth medium. Alternatively, a mineral salt composi- tion having one-half the concentration of all of the mineral salts except iron and EDTA can be used in modified fourth medium A or C. The fourth medium which is used to root the germi- nated embryoids may be selected from a group consist- ing of three media A-C. Each medium contains l %-2%, preferably 1%, sucrose and a gelling sub- stance, preferably 0.2% Gelrite. The pH is 5.5-6.0, preferably 5.8. Each medium is sterilized by autoclaving except the vitamins and hormones which are sterilized by membrane filtration. Fourth medium A comprises mineral salts and vita- mins which are the same as in the first medium. It is preferred to use modified Nitsch's vitamins A. Prefera- bly, 100 mg/I myoinositol is utilized. No hormone is present in this medium. It is also possible to utilize min- eral salts D or mineral salts E in this medium. Fourth medium B comprises mineral salts, vitamins and a hormone. The mineral salts are the same as in the first medium, except that 300 mg/I Nf4H2P04 and 2.5 g KN03 are used in place of the Nf4N03 and KN03. This combination will be referred to herein as mineral salts F. Likewise, the vitamins are the same with modi- fied Nitsch's vitamins A preferred. 100 mg/I myoinosi- tol and 1% sucrose are present: The hormone is IAA with a preferred concentration of 0.5 mg/I. Fourth medium C comprises mineral salts, vitamins and a hormone. The mineral salts and vitamins are the same as in fourth medium A, including the use of min- eral salts D or E. The hormone is either IAA or IBA, at a concentration of 0.1-0.5 mg/I. Myoinositol is present at 100 mg/I. After the roots have formed, the plantlets are ready to be potted in soil. The plantlets are potted by transfer- ring the plantlets to soil which is well moistened and contained in a high humidity chamber. Once the plant- lets are established, they are removed from the high humidity chamber, transplanted to soil, and grown to maturity to produce seeds. In the second embodiment, the first step comprises the culturing of the immature embryo on a first medium B to induce pre-callus formation. Alternatively, the immature embryo is first cultured on a pre-conditioning
  • 6. 4,837,152 109 medium before culturing on the first medium B. The pre-conditioning medium is the same as the first medium A, except that the concentration of 2,4-D is about 1 mg/I to about 2 mg/I. Modified Nitsch's vitamins A is preferably utilized. The immature embryo is cultured on a pre-conditioning medium in the dark at room tem- perature for about 10 to about 21 days, preferably 14 days, before transferring to first medium B. First medium B comprises mineral salts, vitamins, sucrose, 2,4-D and optionally amino acids. The mineral salts are the same as·described for first medium A. The vitamins are also the same as for first medium A, i.e., modified Nitsch's vitamins A, modified Nitsch's vita- mins B or modified Nitsch's vitamins C. Modified Nitsch's vitamins A is preferred. Myoinositol is used at mg/I 2,4-D and 0.0264 mg/I ABA. Myoinositol is pres- ent at 100 mg/I or 1,600 mg/I, and sucrose at 2%. The pH is 5.5-6.0, preferably 5.8. It is preferred to use third medium C without coconut milk and with L-glutamine 5 as the amino acid. The third medium C may also contain 1,000-4,000 mg/I mannitol. After maturing the embryoids in the third medium C, the embryoids are germinated by culturing on a fourth medium. The culturing of the embryoids for germina- 10 tion is generally performed as described above for the ·· ' first --embodiment. It is preferred to first use fourth me- dium D as the germinating medium with one or more subcultures on this medium. The germinated embryoids will be transferred as discussed in the first embodiment, 15 generally to modified third medium B. The recalcitrant embryoids will preferably be subcultured on fourth medium E in the light for 7-14 days, and then back to fourth medium D and cultured as previously described. a concentration of 100 mg/I or 1,600 mg/I. 2%-3%, preferably 2%, sucrose and a gelling substance, prefera- bly 0.2% Gelrite, are present. The hormone is 2,4-D, preferably at 10 mg/I concentration. The first medium may optionally contain amino acids, such as L-gluta- 20 mine or a mixture of L-glutamine, L-methionine and L-asparagine. This latter mixture will be referred to hereinafter as amino acids A. Preferably 800 mg/I L- glutamine or a mixture of 800 mg/I L-glutamine, 350 mg/I L-methionine and 200 mg/I L-asparagine is used. 25 The medium has a pH of 5.5-6.0, preferably 5.8. The medium is sterilized by autoclaving all of the compo- nents except the vitamins, 2,4-D and amino acids, which are filter-sterilized. The immature embryo is cultured The fourth medium which may be utilized for germi- nating the embryoids is selected from a group consisting of four different media, herein referred to as fourth media D-G as discussed above. Each fourth medium contains 2%-3%, preferably 2%, sucrose and a gelling substance, preferable 0.2% Gelrite. The pH is 5.5-6.0, preferably 5.8. Each medium is sterilized by autoclav- ing, except the vitamins, hormones and amino acids, which are filter-sterilized. Fourth medium D comprises mineral salts, vitamins and a hormone. The mineral salts and vitamins are the on this medium for about _7-14 days, preferably 7 days, before transferring to a second medium D. The cultur- ing is conducted in the light, such as either Grow-Lux fluorescent light or cool white fluorescent light, with a photoperiod of 16 hours per day. The pre-callused im- mature embryo is cultured on second medium D to complete callus formation, form embryoids, and to par- tially mature the embryoids. Culturing on the second medium D is performed in the light as previously de- scribed for about 14-35 days, preferably for 21 days. 30 same as for first medium B, with modified Nitsch's vitamins B preferred. In addition, mineral salts D or one-half concentration of all mineral salts may also be utilized. Myoinositol is present at 100 mg/I or 1,600 mg/I, and sucrose at 2%. The hormone is a mixture of 35 NAA, BA, t-zeatin and kinetin. The concentrations of each are preferably 0.05-0.15mg/l NAA. about 0.033 mg/I BA, about 0.033 mg/I t-zeatin, and about 0.033 mg/I kinetin. It is preferred to use 0.15 mg/I NAA. This Second medium D comprises mineral salts, vitamins, 40 a hormone, and optionally amino acids. The mineral salts are the same as used in the first medium B. The vitamins are also the same, but are preferably modified Nitsch's vitamins B. Myoinositol may be used at a con- centration of 100 mg/I or 1,600 mg/I. The hormone is a 45 mixture of 2,4-D, IAA and ABA, preferably at a con- centration of about 3 mg/I 2,4-D, 2 mg/I IAA and 0.0264 mg/I ABA. The amino acids which may option- ally be present are the same as in the first medium B. combination of hormones is known in the art as Collins' germinating hormones. Fourth medium E is the same as fourth medium D, except for the hormone concentrations. It is preferred to use about 0.05 mg/ml NAA, about 0.33 mg/I BA, about 0.33 mg/I t-zeatin and about 0.33 mg/I kinetin in fourth medium E. This combination of hormones is also known as Collins' germinating hormones. Fourth medium F and fourth medium G are the same as third medium A and third medium B described above for the first embodiment. The next step is to further mature the embryoids by culturing in a liquid medium, hereinafter referred to as third medium C. Culturing in this medium is conducted in the light as previously described for about 7-14 days, preferably 7 days, with shaking. It is preferred to utilize baffied flasks for proper aeration and to perform gentle shaking on a vertical shaker with slow rotation, prefera- bly 5-10 rpm. Third medium C comprises mineral salts, vitamins, amino acids and a hormone. The mineral salts are the same as in the first medium B. The vitamins are also the same, but preferably modified Nitsch's vitamins B. The amino acids may either be L-glutamine at 500-800 mg/I, amino acids A or a mixture of L-alanine, L-arginine and L-serine at concentrations of 250 mg/I, 250 mg/I and 100 mg/I, respectively. This mixture will be referred to as amino acids B. The medium may optionally contain coconut milk at 0.5% concentration. The hormone is a mixture of 2,4-D and ABA at a concentration of 0.5 50 Following germination, the shoots are rooted by culturing on a fifth medium. THe culturing of the shoots is performed as described above for the first embodiment. The fifth medium may be selected from a group of three media, hereinafter referred to as fifth 55 media A-C. Fifth media A, B and C are the same as fourth media A, B and C, respectively, for the first embodiment. Plants are transferred to the soil as previ- ously described. This process is useful for regenerating plantlets from 60 tissue of many cultivars of soybean. The process is use- ful for regenerating plantlets from Glycine max (L.) Merrill cv. Williams 82, Beeson 80, Miami, Century 84, Forrest, Corsoy 79, Mitchell 450, Evans, Gnome and Northrup King variety S-18-84-8032023. All cultivars 65 are available commercially or by contacting Dr. Rich- ard L. Bernard, University of Illinois Department of Agronomy, Urbana, Ill. 61801 (Northern cultivars) or by contacting Dr. E. E. Hartwig, U.S. Department of
  • 7. 4,837,152 1211 Agriculture, Agricultural Research Center, Stoneville, Mo. 38776 (Southern cultivars). The present invention will be further described by reference to the following non-limiting examples. In these examples, culturing in the light refers to culturing in light having a photoperiod of 16 hours per day at 25°-29° C. unless indicated otherwise. The temperature during the 8 hour dark phase is 23°-24° C. unless indi- cated otherwise. In all ofthe media, any one ofthe three modified Nitsch's vitamins could be used. EXAMPLE 1 Preparation of Solutions Component KH2P04 5 H3B03 FeS04.7H20 -continued Weight (mg) 850 3J 279.5 Component KI CoS04.7H20 Na2 EDTA E. Mineral Salts F Weight (mg) 4.J5 O.J25 208.5 A !OX stock solution of mineral salts F was prepared 10 by dissolving the following components in 500 ml of distilled, deionized water. Component Weight (mg) Component Weight (mg) The following stock solutions were prepared for use 15 in making the media described in further detail below. Nff4H2P04 KN03 CaCJ2.2H20 MgS04'2H20 KH2P04 H3B03 FeS04.7H20 J,500 J2,500 2,200 J,850 MnS04.H20 ZnS04.7H20 Na2Mo04.2H20 CuS04.5H20 84.5 43 1.25 O.J25 4.15 O.J25 1. Mineral Salts A. MS Minor Salts A lOOX stock solution of the MS minor salts was 20 prepared by dissolving the following components in 500 ml of distilled, deionized water. Component Weight (mg) Component Weight (mg) 25 ZnS04.7H20 430 KI 41.5 Na2Mo04.2H20 J2.5 H3B03 310 CuS04.5H20 1.25 MnS04.H20 845 CoCl2.6H20 1.25 850 3J 279.5 KI CoS04.7H20 Na2 EDTA 2. Vitamins A. Nitsch's Vitamins A 208.5 A lOOX stock solution of vitamins was prepared by dissolving the following components in distilled, deion- ized water of a total volume of 500 ml. The folic acid was first dissolved in 5 ml of IN KOH before adding it B. Mineral Salts A 30 to the water. A !OX stock solution of mineral salts A was prepared, by dissolving the following components in 500 ml of distilled, deionized water. Component Weight (mg) Component Weight (mg) Component Weight (mg) Component Weight (mg) nicotinic acid 250 thiamine.HCl 25 glycine JOO folic acid 25 pyridoxine.HCl 25 biotin 2.5 B. Nitsch's Vitamins B A lOOX stock solution of vitamins was prepared by N"4 Citrate KN03 CaCl2.2H20 MgS04.2H20 KH2P04 H3B03 FeS04.7H20 22,620 5,050 2,200 J,850 850 31 279.5 MnS04.H20 ZnS04.7H20 Na2Mo04.2H20 CuS04.5H20 KI CoS04.7H20 Na2 EDTA 84.5 43 1.25 O.J25 4.J5 0.125 208.5 40 dissolving the following components in distilled, deion- ized water of a total volume of 500 ml. The folic acid was first dissolved in 5 ml of IN KOH before adding it to the water. C. Mineral Salts B 45 A lOX stock solution of mineral salts B was prepared by dissolving the following components in 500 ml of distilled, deionized water. Component Weight (mg) Component Weight (mg) N"4 Citrate 22,620 ZnS04.H20 43 CaCl2.2H20 2,200 Na2Mo04.2H20 1.25 MgS04.7H20 1.850 CuS04.5H20 0.125 KH2P04 850 KI 4.J5 H3B03 3J CoS04.7H20 O.J25 MnS04.7H20 84.5 Na2 EDTA 208.5 FeS04.7H20 279.5 D. Mineral Salts C 50 55 A !OX stock solution of mineral salts C was prepared 60 by dissolving the following components in 500 ml of distilled, deionized water. Component nicotinic acid glycine pyridoxine.HCI Weight (mg) 25 100 25 C. Nitsch's Vitamins C Component thiamine.HCl folic acid biotin Weight (mg) 500 25 2.5 A IOOX stock solution of vitamins was prepared by dissolving the following components in distilled, deion- ized water of a total volume of 500 ml. The folic acid was first dissolved in 5 ml of IN KOH before adding it to the water. Component nicotinic acid glycine pyridoxine.HCI Weight (mg) 250 JOO 25 D. Sussex's Vitamins Component thiamine.HCl folic acid biotin Weight(mg) 500 25 2.5 Component Weight (mg) Component Weight (mg) ----------------------''----~- 65 A lOOX stock solution of Sussex's vitamins was pre- ~~03 1 ~:: ~:;g4 4 71:f~ !~·5 pared by dissolving 750 mg of thiamine hydrochloride CaCJ2 2H2o 2.200 Na2Mo04.m2o 1.25 and 75 mg of pyridoxine hydrochloride in 500 ml of MgS04.2H20 J.850 CuS04.5H20 0.125 distilled, deionized water.
  • 8. 4,837,152 1413 3. Amino Acids A. L-Glutamine An 80 mg/ml stock solution was prepared by dis- solving 20 g ofL-glutamine in 250 ml of distilled, deion- 5 ized water. B. Amino Acids A A stock solution of amino acids A was prepared by dissolving 20 g of L-glutamine, 8.75 g of I-methionine and 5 g of L-asparagine in 250 ml of distilled, deionized 10 water. C. Sussex's Amino Acids A stock solution of Sussex's amino acids was pre- pared by dissolving 20 g of L-glutamine, 2.5 g of serine and 2.5 g of L-asparagine in 250 ml of distilled, deion- 15 ized water. D. Amino Acids B A stock solution of amino acids B was prepared by dissolving 6.25 g of L-alanine, 6.25 g of L-arginine and 2.5 g of L-serine in 250 ml of distilled, deionized water. 20 4. Iron and EDTA mine hydrochloride, 20 g of sucrose and 2 g of Gelrite in 800 ml of distilled, deionized water. 5 ml of the iron and EDTA stock solution were then added. The mix- ture was brought to the desired volume with distilled, deionized water, depending on the amount of vitamins and hormone stock solutions to be added after autoclav- ing. The final volume when all components were added was one liter. The pH was adjusted to 5.8 with 1 N HCI or 1 N NaOH. The mixture was autoclaved at 18 psi for 15 minutes. 10 ml of either modified Nitsch's vitamins A stock solution, modified Nitsch's vitamins B stock solution, or modified Nitsch's vitamins C stock solution were filter- sterilized by passing through a 0.22 micron Millipore membrane filter and added to the cooling medium. The appropriate volume of the 2,4-D stock solution, and optionally the appropriate volume of ABA, was added after filter-sterilization to give the desired concentra- tion, i.e., 5-19 mg/I 2.4-D, and optionally 0.0264 mg/I ABA, to the cooling medium. If amino acids were de- sired, either 2.19 g!I of L-glutamine were added to the 800 ml of water, or 10 ml of filter-sterilized amino acids A stock solution was added to the cooling medium. The A lOOX stock solution of iron and EDTA was pre- pared by dissolving 1.39 g of iron (II) sulfate heptahy- drate and 1.86 g of disodium-EDTA in 500 ml of dis- tilled, deionized water. 25 medium was then poured into petri dishes. 5. Hormones (A) A 0.264 mg/ml stock solution of ABA was pre- pared by dissolving 26.4 mg of ABA in 20 ml of IM 30 NaHC03 and diluting to 100 ml with distilled, deionized water. 2. First Medium B First medium B was prepared as described above for first medium A, using 10 mg/1 2,4-D. If first medium B contained 1,600 mg/I myoinositol, an additional 1.5 g of myoinositol were also dissolved in the 800 ml of water. 3. Pre-Conditioning Medium(B) A I mg/I stock solution of BA was prepared by dissolving 100 mg of BA in 20 ml of lN NaOH and diluting to 100 ml with distilled, deionized water. (C) A 1 mg/ml stock solution of 2,4-D was prepared by dissolving 100 mg of 2,4-D in 20 ml of 70% ethanol and diluting to 100 ml with distilled, deionized water. Pre-conditioning medium was prepared as described 35 for the first medium, having a concentration of 1.2 mg/I 2,4-D. The medium was poured into petri dishes. (D) A 1 mg/ml stock solution of IBA was prepared by dissolving 100 mg of IBA in 20 ml of 70% ethanol 40 and diluting to 100 ml with distilled, deionized water. 9E) A 1 mg/ml stock solution of kinetin was prepared by dissolving 100 mg of kinetin in 20 ml of IN NaOH and diluting to 100 ml with distilled, deionized water. (F) A 1 mg/ml stock solution of t-zeatin was prepared by dissolving 100 mg of t-zeatin in 5 ml of SN HCI and 45 diluting to 100 ml with distilled, deionized water. (G) A 0.0025 mg/ml stock solution of picloram was prepared by dissolving 0.24 mg of picloram in 20 ml of warm, distilled, deionized water and diluting to 100 ml with distilled, deioniied water. 50 (H) A 0.1 mg/ml stock solution of IAA was prepared by dissolving 10 mg ofIAA in 20 ml of70% ethanol and diluting to 100 ml with distilled, deionized water. The stock solution was stored in a bottle wrapped in alumi- num foil in a refrigerator. The solution was prepared 55 fresh every one to two months. (I) A 1 mM stock solution of GA3 was prepared by dissolving 34.6 mg of GA3 in 20 ml of absolute ethanol and diluting to 100 ml with distilled, deionized water. EXAMPLE 2 Preparation of Media 1. First Medium A 60 The first medium A was prepared by dissolving one 65 packet of Murashige minimal organics solution without sucrose (Gibco Laboratories Catalog No. 510-3118), which contained 100 mg myoinositol and 0.4 mg thia- 4. Second Medium A. Second Medium A Second medium A was prepared by dissolving 20 g of sucrose and 4 g of Gelrite, 100 mg of casein hydroly- sate, and either 100 mg or 1.5 g of myoinositol in 800 ml of distilled, deionized water. 100 ml of mineral salts A stock solution were added, and the mixture brought to the desired volume as described above. The pH was adjusted to 5.8, and the mixture autoclaved as previ- ously described. 10 ml of either modified Nitsch's vita- mins A stock solution, modified Nitsch's vitamins B stock solution or modified Nitsch's vitamins C stock solution were filter-sterilized and added to the cooling medium. The appropriate volumes of the hormone stock solutions were filter-sterilized and added to the cooling medium to give the desired concentration, i.e., I mg/I IAA, 1 mg/I t-zeatin, 0.0264 mg/ 1 ABA, and 0.0096 mg/I picloram. The medium was poured into petri dishes. B. Second Medium B Second medium B was prepared as described for first medium A, except that the appropriate amounts of the IAA and t-zeatin stock solutions were used in place of 2,4-D to give the desired concentration, i.e., I mg/I IAA and 0.5 mg/I t-zeatin. In addition, 1.5 g of myoino- sitol were also dissolved in the water, if desired. C. Second Medium C Second medium C was prepared as described for second medium A, except that mineral salts B stock solution was used and 100 mg of myoinositol were dis- solved in the water.
  • 9. 4,837,152 1615 D. Second Medium D Second medium D was prepared as described for first medium B, except that the appropriate amounts of the 2,4-D, IAA and ABA stock solutions were used in place of 2,4-D only to give the desired concentrations, i.e, 3 5 mg/I 2,4-D, 2 mg/I IAA, and 0.0264 mg/I ABA. Modi- fied Nitsch's vitamins B was preferred. 5. Third Medium (Fourth Medium) A. Third Medium A (Fourth Medium F) 10 Third medium A was prepared by dissolving 20 g of sucrose, w g of Gelrite, and either 1.5 g or 100 mg of myoinositol in 800 ml of distilled, deionized water. 100 ml of mineral salts C stock solution was added, and the volume brought to the desired level as described above. 15 The pH was adjusted to 5.8 and autoclaved as described above. 10 ml of Sussex's vitamins stock solution, 10 ml of Sussex's amino acids stock solution and the appropri- ate volumes of the IAA, kinetin, ABA and GA3 stock solutions to give the desired concentrations, i.e., 0.01 20 mg/I IAA, 0.1 mg/I kinetin, 0.1 mg/I ABA and 0.1 mg/I GA3, were filter-sterilized and added to the cool- ing medium, which was then poured into petri dishes. B. Third Medium B (Fourth Medium G) Third medium B was prepared as described for first 25 medium A, except that the appropriate amounts of the BA and IBA stock solutions were used in place of2,4-D to give the desired concentrations, i.e., 0.2 mg/I BA and 0.005 mg/I IBA. The medium was poured into petri dishes. Modified third medium B, having one-half the con- centration of macroelements except iron, was prepared as described for first medium A except that only one- half packet of Murashige medium was dissolved. 50 mg 30 of myoinositol and 0.2 mg of thiamine hydrochloride 35 were also dissolved in the water. 10 ml of the iron and EDTA stock solution and 5 ml of the MS minor salts stock solution were also added. Modified third medium B, having one-half the con- centration of all mineral salts except iron was prepared 40 as described above except that the MS minor salts stock solution was not added. C. Third Medium C Third medium C was prepared as described for first medium B, except that no Gelrite was used, either 45 6.25-10 ml of the L-glutamine stock solution, 10 ml of amino acids A stock solution or 10 ml of the amino acids B stock solution were used, and the appropriate amounts of 2,4-D and ABA were used to give the de- sired concentrations, i.e., 0.5 mg/I 2,4-D and 0.0264 50 mg/I ABA. Modified Nitsch's vitamins B was pre- ferred. If coconut milk was present, it was added to a final concentration of 0.5%. The medium was poured into buffered flasks. appropriate amount of IAA to give the desired concen- tration, i.e., 0.5 mg/I, were used. The medium was poured into petri dishes. C. Fourth Medium C (Fifth Medium C) Fourth medium C, including one-half strength mac- roelements except iron, or all mineral salts except iron and EDTA, was prepared as described for fourth me- dium A except that the appropriate amounts of either the IAA or the IBA stock solution were added to give the desired concentration, i.e., 0.1-0.5 mg/I. D. Fourth Medium D Fourth medium D was prepared as described for first medium B, except that the appropriate amounts of NAA, BA, t-zeatin and kinetin stock solutions were used to give the desired concentrations, i.e., 0.05-0.15 mg/I NAA, 0.033 mg/I BA, 0.033 mg/I t-zeatin and 0.033 mg/I kinetin. Modified Nitsch's vitamins B was preferred. Modified fourth medium D, having one-half the concentration of macroelements except iron and EDTA or of all mineral salts except iron and EDTA, was prepared analogously to that previously described. E. Fourth Medium E Fourth medium E or modified fourth medium E was prepared as described for fourth medium D, except that the desired concentrations of hormones were 0.05 mg/I NAA, 0.33 mg/I BA, 0.33 mg/I t-zeatin and 0.33 mg/I kinetin. EXAMPLE 3 Soybean Regeneration Immature embryos were isolated from pods of the soybean Glycine max (L.) Merrill cv. Corsoy 79 or Mitchell 450, when the pods were 1.5 to 5.0 cm in length. The soybean pods were collected each morning and placed in a sterile 18 oz. bottle. Surface-sterilizing agents employed separately were as follows: 70% etha- nol (1 min.), 15% concentrated Clorox TM and 0.1 % Tween 80 (8 min.), and washing three times with dis- tilled, deionized water. Sterile pods were placed in the top of a sterile petri dish (100 mm X25 mm). Each pod was individually cut with scissors. The ovules (two to three per pod) were carefully pressed out of the pod into the bottom petri dish (sterile). A pair of forceps and a needle probe were used to remove the immature em- bryo from each ovule. The embryos were plated onto the first medium A contained in a petri dish. First me- dium A contained 10 mg/I 2,4-D, 0.0264 mg/I ABA, 2.19 g/1 L-glutamine and modified Nitsch's vitamins A. The petri dish was placed in the light (cool white) and cultured for 28 days to form calli and embryoids. At this time, each callus with embryoids was trans- ferred to second medium C and cultured on this me- dium for 28 days in the light (cool white). The callus 6. Fourth Medium A. Fourth Medium A (Fifth Medium A) Fourth medium A was prepared as described for first medium A, except that only 10 g of sucrose were used and 2,4-D was excluded. The medium was poured into petri dishes. Fourth medium A, having one-half the concentration of macroelements except iron, or of all mineral salts except iron, was prepared analogously to that described for third medium B. 55 with mature embryoids was then transferred to a third medium B and cultured on this medium for 28 days in the light (cool white). The germinating embryos were transferred to modified third medium B containing one- half concentration of all mineral salts except iron and B. Fourth Medium B (fifth Medium B) Fourth medium B was prepared as described for second medium A, except that 10 g of sucrose, 2 g of Gelrite, 100 ml of mineral salts F stock solution and the 60 EDTA and cultured for 28 days in the light (cool white). The germinating embryos were again trans- ferred to this medium and cultured an additional 28 days. The germinated embryoids were then transferred to fourth medium B. The shoots were cultured on this 65 medium for 28 days in the light (cool white). During this time, the shoots formed roots. The Gelrite was washed off the roots of the plantlets with sterile, distilled, deionized water. The plantlets
  • 10. 4,837,152 1817 for 41 days in the light (cool white). The callus with mature embryoids-was then transferred to third medium A and cultured in the light. The germinating embryos are cultured and transferred as described in Example 3 were then transferred to soil in a quart Mason jar. The bottom of the Mason jar was covered with sterile, acti- vated charcoal. Four inches of an autoclaved, equal mixture of vermiculite, Perlite and potting soil were placed over the charcoal The plantlets were planted in the soil and the soil was well moistened with sterile, distilled, deionized water. Parafilm TM was placed over the jar and the cap was screwed over the Parafilm. The jar was then placed in a Percival growth chamber at 24° 5 to produce plants, except that only the macroelements, except iron and EDTA, are at one-half concentration in modified third medium B. C., having a photoperiod of 16 hours per day. After 12 10 days, the jar was removed ·from the growth chamber and placed in a sweater box in the greenhouse. A second sweater box was placed perpendicular to and over the first sweater box and a paper towel was placed over it to provide for diffuse sunlight. The greenhouse maintained 15 a temperature of 29° C.±3° C. during the day and 21° C.±2° C. during the night, and a photoperiod of 16 hours per day. After one week, the Parafilm was re- moved from the jar. Four days later, the regenerated plants were transplanted to a 6" pot containing an equal 20 mixture of vermiculite, perlite and potting soil, and returned to the sweater boxes. The regenerated plant flowered and formed pods which contained developing ovules. EXAMPLE IO Soybean plants are regenerated as described in Exam- ple 9, except that the embryos were cultured on first medium A for 28 days, second medium C and third medium B were utilized, and the callus with embryoids was cultured on second medium C for 31 days. EXAMPLE 11 Soybean plants are regenerated as described in Exam- ple 10, except that second medium B was used in place of second medium C. EXAMPLE 12 EXAMPLE4 Soybean Regeneration Soybean plants were regenerated from immature embryos as described in Example 3, except that second medium A was used in place of second medium C. Immature embryos were isolated from the Corsoy 79 cultivar as described in Example 3, plated on first me- dium B containing 10 mg/I 2,4-D, and cultured in the 25 light (Grow-Lux). After 8 days, the pre-callus wa5 transferred to second medium D and cultured in the light (Grow-Lux) for 19 days. The callus was maturing embryoids was then placed in third medium C, which is EXAMPLE 5 30 a liquid and cultured in the light (Grow-Lux) with gen- tle shaking for 13 days. The callus with mature embry- oids was then transferred to fourth medium D having 0.15 mg/I NAA and cultured in the light (Grow-Lux) for 29 days. The embryoids were transferred to fourth Immature embryos were isolated from the Corsoy 79 cultivar as described in Example 3, plated on first me- dium A containing 5 mg/I 2,4-D, and cultured in the 35 light (cool white). After 28 days, the callus with embry- oids was transferred to second medium A and cultured for 30 days in the light (cool white). The callus with mature embryoids was then transferred to third medium B and cultured in the light (cool white). The germinat- 4-0 ing embryos are cultured and transferred as described in Example 3 to produce plants, except that only the mac- roelements, except iron and EDTA, are at one-half concentration in modified third medium B. medium D having 0.15 mg/I NAA and cultured in the light (Grow-Lux). The germinating embryoids are cul- tured on and transferred from fourth medium D as described in example 3, i.e., to modified fourth medium G and then to fifth medium for germination and root formation, except that the light is grow-Lux and only the macroelements, except iron and EDTA, are at one- half concentration in modified fourth medium G. Em- bryoids which have not germinated on fourth medium Dare cultured on fourth medium E for 70-14 days, and EXAMPLE6 45 then returned to fourth medium D and cultured as above. EXAMPLE 13 Immature embryos were isolated from the Williams Soybean plants are regenerated as described in Exam- ple 5, except that second medium C was used in place of second medium A, and culturing on this medium was for 24 days. EXAMPLE 7 50 82 cultivar as described in Example 3, plated on first medium B containing IO mg/12,4-D, and cultured in the light (cool white). After 14 days, the pre-callus was transferred to second medium D and cultured in theSoybean plants are regenerated as described in Exam- ple 6, except that third medium A was used in place of third medium B, and culturing on second medium.B was 55 for 28 days. EXAMPLE 8 Soybean plants are regenerated as described in Exam- ple 7, except that second medium B was used in place of 60 second medium C. light (cool white) for 14 days. The callus with maturing embryoids was then placed in third medium C, which is a liquid, and cultured in the light (cool white) for 13 days. The callus with mature embryoids was then trans- ferred to fourth medium D having 0.15 mg/I NAA and cultured in the light (cool white) for 29 days. The em- bryoids were transferred to fourth medium D having 0.15 mg/I NAA and cultured in the light (Grow-Lux). The germinating embryoids are cultured on and trans- EXAMPLE 9 ferred from fourth medium D as described in Example Immature embryos were isolated from the Williams 3, i.e., to modified fourth medium G and then to fifth 82 cultivar as described in Example 3, plated on first 65 medium for germination and root formation, except that medium A containing 5 mg/I 2,4-D, and cultured in the only the macroelements, except iron and EDTA, are at light (cool white). After 18 days, the callus with embry- one-half concentration in modified fourth medium G. oids was transferred to second medium A and cultured Embryoids, which have not germinated on fourth me-
  • 11. 19 4,837,152 20 dium Dare cultured on fourth medium E for 7-14 days, and then returned to fourth medium D and cultured as above. While the invention has been described in connection with specific embodiments thereof, it will be under- 5 stood that it is capable of further modifications. This application is intended to cover any variations, uses or adaptations of the invention following, in general, the principles of the invention and including such depar- tures from the present disclosure as come within known 10 and customary practice within the art. to which the invention pertains. What is claimed is: 1. A process for regenerating soybean plants via so- matic embryogenesis which comprises: 15 (a) culturing a soybean embryo on a solid first me- dium which comprises MS mineral salts modified to contain 41.7 mg/I iron sulfate heptahydrate (ISH) and 55.9 mg/I disodium ethylenediamine tetracetic acid (Na2EDTA), vitamins selected from 20 the group consisting of Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modi- fied to contain 10.4 mg/l of thiamine hydrochlo- 25 ride, 2%-3% sucrose, .myoinositol and 5-10 mg/I 2,4-dichlorophenoxyacetic acid (2,4-D) in the light for 25-45 days to induce callus and embryoid for- mation; (b) subculturing the callus and embryoids on one or 30 more solid second media which are selected from the group consisting of: (i) second medium A, which comprises MS mineral salts modified to contain no ammonium nitrate, 4,524 mg/I ammonium citrate, 1,010 mg/I potas- 35 sium nitrate, 41.7 mg/I ISH and 55.9 mg/l Na2EDTA, vitamins selected from the group consisting of Nitsch's vitamins modified to con- tain 10.4 mg/I thiamine hydrochloride and 0.5 mg/l nicotinic acid and Nitsch's vitamins modi- 40 fied to contain 10.4 mg/I of thiamine hydrochlo- ride, 2%-3% sucrose, 100 mg/l casein hydroly- sate, myoinositol, 1 mg/I indoleacetic acid (IAA), 1 mg/I t-zeatin, 0.0264 mg/l abscisic acid (ABA) and 0.0096 mg/I picloram; 45 (ii) second medium B, which comprises MS min- eral salts modified to contain 41.7 mg/I ISH and 55.9 mg/I Na2 EDTA, vitamins selected from the group consisting of Nitsch's vitamins modi- fied to contain 10.4 mg/I thiamine hydrochloride 50 and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I ofthiamine hydro- chloride, 2%-3% sucrose, myoinositol, 1 mg/I IAA and 0.5 mg/I t-zeatin; and (iii) second medium C, which comprises MS min- 55 era! salts modified to contain no ammonium ni- trate, no potassium nitrate, 4,524 mg/I ammo- nium citrate, 41.7 mg/I ISH, and 55.9 mg/I Na2EDTA, vitamins selected from the group consisting of Nitsch's vitamins modified to con- 60 tain 10.4 mg/l thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modi- fied to contain 10.4 mg/I of thiamine hydrochlo- ride, 2%-3% sucrose, 100 mg/1 casein hydroly- sate, myoinositol, 1 mg/I IAA, 1 mg/I t-zeatin, 65 0.0264 mg/I ABA and 0.0096 mg/I picloram in the light for 20-45 days per subculture, to mature the embryoids; (c) subculturing the mature embryoids on one or more solid third media which are selected from the group consisting of: (i) third medium A, which comprises MS mineral salts modified to contain 2,000 mg/I ammonium nitrate, 600 mg/I potassium nitrate, 41.7 mg/I of ISH and 55.9 mg/I Na2EDTA, Sussex's vita- mins, Sussex's amino acids, 2%-3% sucrose, myoinositol, 0.01 mg/I IAA, 0.1 mg/I kinetin, 0.1 mg/l ABA and 0.1 mg/I gibberellic acid (GA3); and (ii) third medium B, which comprises MS mineral salts modified to contain 41.7 mg/I ISH and 55.9 mg/I Na2EDTA, vitamins selected from the group consisting of Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride, and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I ofthiamine hydro- chloride, 2%-3% sucrose, myoinositol, 0.2 mg/I benzyl adenine (BA) and .0.005 mg/I indole-3- butyric acid (IBA) in the light for 20-45 days for subculture, to induce shoot formation; and (d) subculturing the shoots on one or more solid fourth media which are selected from the group consisting of: (i) fourth medium A, which comprises MS mineral salts modified to contain 41.7 mg/I ISH and 55.9 mg/I Na,,EDTA, vitamins selected from the group consisting of Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride, and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I of thiamine hydro- chloride, 1%-2% sucrose and myoinositol; (ii) fourth medium B, which comprises MS mineral salts modified to contain no ammonium nitrate, 300 mg/I N~2P04, 2,500 mg/I potassium nitrate, 41.7 mg/I ISH and 55.9 mg/I Na2EDTA, vitamins selected from the group consisting of Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I of thiamine hydrochloride, 1%-2% sucrose, myoinositol and 0.5 mg/I IAA, and; (iii) fourth medium C, which comprises MS min- eral salts modified to contain 41.7 mg/I ISH and 55.9 mg/l Na2EDTA, vitamins selected from the group consisting of Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/l nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I of thiamine hydro- chloride, 1%-2% sucrose, myoinositol and a hormone selected from the group consisting of 0.1--0.5 mg/I IAA and 0.1--0.5 IBA in the light for 20-45 per subculture, to·induce root formation whereby plants are obtained. 2. The process of claim 1 wherein the MS mineral salts of the third medium B, fourth medium A and fourth medium C are further modified to contain one- half the concentration of the macroelements. 3. The process of claim 1 wherein the MS mineral salts of the third medium B, fourth medium A and fourth medium C are further modified to contain one- half the concentration of all the mineral salts except iron and EDTA. 4. The process of claim 1 wherein the concentration of myoinositol in third medium A is 1,500 mg/I and in all other media is I00 mg/I.
  • 12. 4,837,152 2221 5. The process of claim 2 wherein the concentration of myoinositol in third medium A is 1,500 mg/I and in all other media is l00 mg/I. 6. The process of claim 3 wherein the concentration of myoinositol in third medium A is 1,500 mg/I and in 5 all other media is 100 mg/I. 7. The process of claim 1 wherein the vitamins in third medium A is Sussex's vitamins and the vitamins in all other media is Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nico- 10 tinic acid. 8. The process of claim 1 wherein the vitamins in third medium A is Sussex's vitamins and the vitamins in all other media is Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nico- 15 tinic acid. 9. The process of claim 3 wherein the vitamins in third medium A is Sussex's vitamins and the vitamins in all other media is Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nico- 20 tinic acid. 10. The process of claim 4 wherein the vitamins in third medium A is Sussex's vitamins and the vitamins in all other media is Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nico- 25 tinic acid. 11. The process of claim 5 wherein the vitamins in third medium A is Sussex's vitamins and the vitamins in all other media is Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nico- 30 tinic acid. 12. The process of claim 6 wherein the vitamins in third medium A is Sussex's vitamins and the vitamins in all other media is Nitsch's vitamins modified to contain 10.4 mg/ thiamine hydrochloride and 0.5 mg/I nicotinic 35 acid. 13. A process for regenerating soybean plants via somatic embryogenesis which comprises: (a) culturing a soybean embryo on a solid first me- dium which comprises MS mineral salts modified 40 to contain 41.7 mg/I iron sulfate heptahydrate (ISH) and 55.9 mg/I disodium ethylenediamine tetracetic acid (Na2EDTA), vitamins selected from the group consisting of Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 45 0.5 mg/I nicotinic acid and Nitsch's vitamins modi- fied to contain 10.4 mg/I of thiamine hydrochlo- ride, 2%-3% sucrose, myoinositol and about 10 mg/I 2,4-dichlorophenoxyacetic acid (2,4-D) in the light for about 7-14 days to induce pre-callus for- 50 mation; (b) subculturing the pre-callus on a solid second me- dium which comprises MS mineral salts modified to contain 41.7 ISH and 55.9 mg/I Na2EDTA, vitamins selected from the group consisting of 55 Nitsch's vitamins modified to contain 0.9 mg/I thiamine hydrochloride, Nitsch's vitamins modi- fied to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I of thiamine hydro- 60 chloride, 2%-3% sucrose, myoinositol, 3 mg/I 2,4-D, 2 mg/I indoleacetic acid (IAA) and 0.0264 mg/I abscisic acid (ABA) in the light for about 14 to about 35 days, to complete callus formation and embryoid formation and partial embryoid matura- 65 tion; (c) subculturing the embryoids in a liquid third me- dium which comprises MS mineral salts modified to contain 41.7 mg/I ISH and 55.9 mg/I Na2EDTA, vitamins selected from the group con- sisting of Nitsch's vitamins modified to contain 0.9 mg/I thiamine hydrochloride, Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochlo- ride and 0.5 mg/I nicotinic acid and Nitsch's vita- mins modified to contain 10.4 mg/I of thiamine hydrochloride, an amino acid selected from the group consisting of 500-800 mg/I L-glutamine, a mixture of 800 mg/I L-glutamine, 350 mg/I L- methionine and 200 mg/I L-asparagine and a mix- ture of 250 mg/I L-alanine, 250 mg/I L-arginine and 100 mg/IL-serine, 2%-3% sucrose, myoinosi- tol, 0.5 mg/I 2,4-D and 0.0264 mg/I ABA in the light for about 7-14 days, to complete the matura- tion of the embryoids; (d) subculturing the mature embryoids on a solid fourth medium selected from the group consisting of: (i) fourth medium A, which comprises MS mineral salts modified to contain 41.7 mg/I ISH and 55.9 mg/I Na2EDTA, vitamins selected from the group consisting ofNitsch's vitamins modified to contain 0.9 mg/I thiamine hydrochloride, Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I of thiamine hydrochloride, 2%-3% sucrose, myoinositol, 0.05-0.15 mg/I a-naph- thaleneacetic acid (NAA), 0.033 mg/I ben- zyladenine (BA), 0.033 mg/I t-zeatin and 0.033 mg/I kinetin; (ii) fourth medium B, which comprises MS mineral salts modified to contain 41.7 mg/I ISH and 55.9 mg/I Na2EDTA, vitamins selected from the group consisting of Nitsch's vitamins modified to contain 0.9 mg/I thiamine hydrochloride, Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I of thiamine hydrochloride, 2%-3% sucrose, myoinositol, 0.05 mg/I NAA, 0.33 mg/I benzyladenine (BA), 0.33 mg/I t-zeatin and 0.33 mg/I kinetin; (iii) fourth medium C, which comprises MS min- eral salts modified to contain 2,000 mg/I ammo- nium nitrate, 600 mg/I potassium nitrate, 41.7 mg/I oflSH and 55.9 mg/I Na2EDTA, Sussex's vitamins, Sussex's amino acids, 2%-3% sucrose, myoinositol, O.Ql mg/I IAA, 0.1 mg/I kinetin, 0.1 mg/I ABA and 0. 1 mg/I gibberellic acid (GA3); and (iv) fourth medium D, which comprises MS min- eral salts modified to contain 41.7 mg/I ISH and 55.9 mg/I Na2EDTA, vitamins selected from the group consisting ofNitsch's vitamins modified to contain 09 mg/I thiamine hydrochloride, Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I of thiamine hydrochloride, 2%-3% sucrose, myoinositol, 0.2 mg/I BA and 0.005 mg/I indole-3-butyric acid (IBA) in the light for about 20-45 days per subculture, to induce shoot formation; and (e) subculturing the shoots on one or more solid fifth media which are selected from the group consist- ing of:
  • 13. 23 4,837,152 24 medium by culturing in the dark for about 10-21 days on a solid pre-Conditioning medium which comprises MS mineral salts modified to contain 41.7 mg/I ISH and 55.9 mg/I Na2EDTA, vitamins selected from the group consisting of Nitsch's vitamins modified to containing 0.9 mg/I thiamine hydrochloride, Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modi- fied to contain 10.4 mg/I of thiamine hydrochloride, (i) fifth medium A, which comprises MS mineral salts modified to contain 41.7 mg/I ISH and 55.9 mg/I Na2EDTA, vitamins selected from the group consisting ofNitsch's vitamins modified to contain 0.9 mg/I thiamine hydrochloride, 5 Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I of thiamine hydrochloride, 1%-2% sucrose and myoinositol; (ii) fifth medium B;which comprises -MS mineral salts modified to contain no ammonium nitrate, 300 mg/I NI4H2P04, 2,500 mg/I potassium nitrate, 41.7 mg/I ISH and 55.9 mg/I Na2EDTA, vitamins selected from the group consisting of 15 Nitsch's vitamins modified to contain 0.9 mg/I thiamine hydrochloride, Nitsch's vitamins modi- fied to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 10.4 mg/I of thiamine hydro- 20 chloride, 1%-2% sucrose, myoinositol and 0.5 mg/I IAA, and; 10 2%-3% sucrose, myoinositol and 1-2 mg/I 2,4-D. (iii) fifth medium C, which comprises MS mineral salts modified to contain 41.7 mg/I ISH and 55.9 mg/I Na2EDTA, vitamins selected from the 25 group consisting ofNitsch's vitamins modified to contain 0.9 mg/I thiamine hydrochloride, Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid and Nitsch's vitamins modified to contain 30 10.4 mg/I of thiamine hydrochloride, 1%-2% sucrose, myoinositol ·and a hormone selected from the group consisting of 0.1-0.5 mg/I IAA or 0.1-0.5 IBA in the light for 20-45 days per subculture, to induce 35 root formation whereby plants are obtained. 14. The process of claim 13 wherein the MS mineral salts of the fourth medium A, fourth medium B, fourth medium D, fifth medium A and fifth medium C are further modified to contain one-half the concentration 40 of the macroelements. · 15. The process of claim 13 wherein the MS mineral salts of the fourth medium A, fourth medium B, fourth medium D, fifth medium A and fifth medium C are further modified to contain one-half the concentration 45 of all of the mineral salts except iron and EDTA. 16. The process of claim 13 wherein the first medium and second medium further contain an amino acid se- lected from the group consisting of 800 mg/I L-gluta- mine or a mixture of 800 mg/I L-glutamine, 350 mg/I 50 L-methionine and 200 mg/I L-asparagine. 17. The process of claim 14 wherein the first medium and second medium further contain an amino acid se- lected from the group consisting of 800 mg/I L-gluta- mine or a mixture of 800 mg/I L-glutamine, 350 mg/I 55 L-methionine and 200 mg/I L-asparagine. 18. The process of claim 15 wherein the first medium and second medium further contain an amino acid se- lected from the group consisting of 800 mg/I L-gluta- mine or a mixture of 800 mg/I L-glutamine, 350 mg/I 60 L-methionine and 200 mg/I L-asparagine. 19. The process of claim 13 wherein the immature embryo is pre-conditioned prior to culturing on the first 65 20. The process of claim 13 wherein the concentra- tion of myoinositol in fourth medium C is 1,500 mg/I and in all other media is 100 mg/I. 21. The process of claim 14 wherein the concentra- tion of myoinositol in fourth medium C is 1,500 mg/I and in all other media is 100 mg/I. 22. The process of claim 15 wherein the concentra- tion of myoinositol in fourth medium C is 1,500 mg/I and in all other media is 100 mg/I. 23. The process of claim 16 wherein the concentra- tion of myoinositol in fourth medium C is 1,500 mg/I and in all other media is 100 mg/I. 24. The process of claim 17 wherein the concentra- tion of myoinositol in fourth medium C is 1,500 mg/I and in all other media is 100 mg/I. 25. The process of claim 18 wherein the concentra- tion of myoinositol in fourth medium C is 1,500 mg/I and in all other media is 100 mg/I. 26. The process of claim 19 wherein the concentra- tion of myoinositol in fourth medium C is 1,500 mg/I and in all other media is 100 mg/I. 27. The process of claim 13 wherein the vitamins in fourth medium C is Sussex's vitamins and the vitamins in all other media are Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid. 28. The process of claim 14 wherein the vitamins in fourth medium C is Sussex's vitamins and the vitamins in all other media are Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid. 29. The process of claim 15 wherein the vitamins in fourth medium C is Sussex's vitamins and the vitamins in all other media are Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid. 30. The process of claim 16 wherein the vitamins in fourth medium C is Sussex's vitamins and the vitamins in all other media are Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid. 31. The process of claim 17 wherein the vitamins in fourth medium C is Sussex's vitamins and the vitamins in all other media are Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid. 32. The process of claim 18 wherein the vitamins in fourth medium C is Sussex's vitamins and the vitamins in all other media are Nitsch's vitamins modified to contain 10.4 mg/I thiamine hydrochloride and 0.5 mg/I nicotinic acid. • • • • •